PLANTS WITH ENGINEERED ENDOGENOUS GENES

Abstract

Genetically engineered plants expressing altered Glucan Water Dikinase and having elevated levels of starch are provided. Methods of genetically engineering plants to express altered Glucan Water Dikinase, and genetic constructs are provided. Methods of breeding genetically engineered plants homozygous for a mutated gene encoding an altered Glucan Water Dikinase are described. Methods of agricultural processing and animal feed using the genetically engineered plants are also provided.

Claims

1. A genetically engineered plant comprising an engineered nucleic acid encoding an altered Glucan Water Dikinase, wherein the engineered nucleic acid comprises a mutation in a sequence of at least one allele of a gene encoding wild type Glucan Water Dikinase and the plant has an elevated level of starch in comparison to a plant of the same genetic background comprising a wild type Glucan Water Dikinase.

2. The genetically engineered plant of claim 1, wherein the altered Glucan Water Dikinase has an activity that is reduced compared to wild type Glucan Water Dikinase activity.

3. The genetically engineered plant of claim 1, wherein the altered Glucan Water Dikinase is inactive.

4. The genetically engineered plant of claim 1, wherein the mutation is selected from at least one of an insertion, or a deletion of at least one nucleotide in the endogenous nucleic acid.

5. The genetically engineered plant of claim 1, wherein the mutation comprises a substitution of at least one nucleotide in the endogenous nucleic acid.

6. The genetically engineered plant of claims 1, wherein the endogenous nucleic acid includes a sequence with at least 90% identity to the sequence of SEQ ID NO: SEQ ID NO: 1 (Zm GWD coding sequence) or SEQ ID NO: 2 (Sb GWD coding sequence).

7. The genetically engineered plant of claim 1, wherein the mutation is within a target sequence with at least 90% identity to a sequence selected from the group consisting of SEQ ID NO: 3 (Zm GWD Exon 24+introns), SEQ ID NO; 4 (SbGWD Exon 24+introns), SEQ ID NO: 182 (ZmGWD Exon 24 no introns), SEQ ID NO: 183 (Sb GWD Exon 24), SEQ ID NO: 184 (SbGWD Exon 7), SEQ ID NO: 91 (GWDe1a), SEQ ID NO: 92 (GWDe24b), SEQ ID NO: 93 (GWDe24c), and SEQ ID NO: 94 (GWDe25a).

8. The genetically engineered plant of claim 1, wherein the engineered nucleic acid comprises a polynucleotide having a sequence with at least 90% identity to a sequence selected from the group consisting of SEQ ID NOS: 12-40, 106-107, 114-120, 131-146, and 188.

9. The genetically engineered plant of claim 8, wherein the identity is 100%.

10. The genetically engineered plant of claim 1, wherein the altered Glucan Water Dikinase comprises an amino acid sequence with at least 90% identity to a sequence selected from the group consisting of SEQ ID NOS: 45-73 (Zm GWD mutant proteins M1-M29), 121-124 (Zm GWD mutants M32-M36), 126-127 (ZmGWD mutants M38 and M39), and 147-162 (Zm GWD mutants M40-M55).

11. The genetically engineered plant of claim 10, wherein the identity is 100%.

12. The genetically engineered plant of claim 1, wherein the altered Glucan Water Dikinase comprises an amino acid sequence with at least 90% identity to a sequence of SEQ ID NO: 194 (Sb GWD mutant protein Sb4715_1WT+ins) or SEQ ID NO: 195 (Sb GWD mutant protein Sb4715_2 WT+del).

13. The genetically engineered plant of claim 12, wherein the identity is 100%.

14. A method of increasing a starch level in a plant comprising expressing a first nucleic acid encoding a nuclease capable of inducing a double-strand break in a target sequence included in a sequence of an endogenous gene encoding a Glucan Water Dikinase in a plant, and selecting a homozygous plant that includes a mutation in the target sequence and has an elevated level of starch in comparison to a plant of the same genetic background comprising a wild type sequence.

15. The method of claim 14, wherein the step of expressing comprises genetically engineering a plant by contacting at least one plant cell with a vector comprising the first nucleic acid and a first nucleic acid promoter operably linked to the first nucleic acid; and regenerating a genetically engineered plant comprising the mutation from the plant cell.

16. The method of claim 15, wherein a genetically engineered plant is homozygous for the mutation.

17. The method of claim 15, wherein a genetically engineered plant is heterozygous for the mutation, and the step of selecting comprises selfing the heterozygous genetically engineered plant, or crossing to another plant and selecting a progeny that is homozygous for the mutation.

18. The method of claim 17, wherein another plant is a genetically engineered plant heterozygous for the same mutation, or a wild type plant of the same genetic background.

19. The method of claim 14, wherein the mutation comprises at least one of an insertion, or a deletion of at least one nucleotide in the target sequence.

20. The method of claim 19, wherein the mutation is a null mutation.

21. The method of claim 14, wherein the mutation comprises a substitution of at least one nucleotide in the target sequence

22. The method of claim 14, wherein the nuclease is selected from the group consisting of a meganuclease, Cas9 nuclease, a zinc finger nuclease, and a transcription activator-like effector nuclease.

23. The method of claim 22, wherein the nuclease is a meganuclease and is encoded by a sequence with at least 90% identity to a sequence selected from the group consisting of SEQ ID NO: 108 (4715 meganuclease) and SEQ ID NO: 109 (4716 meganuclease).

24. The method of claim 23, wherein the meganuclease is capable of cutting the target sequence, and the target sequence comprises a polynucleotide with the sequence of SEQ ID NO: 41 (target for 4715_GWD-9/10.272) or SEQ ID NO: 42 (target for 4716_3e GWD-7/8276).

25. The method of claim 22, wherein the nuclease is Cas9 nuclease.

26. The method of claim 25, wherein the Cas9 nuclease is encoded with a nucleic acid with at least 90% identity to a sequence of SEQ ID NO: 74 (Cas9 nuclease) or SEQ ID NO: 75 (ZmCas9).

27. The method of claim 15, wherein the vector further comprises a second nucleic acid and a second nucleic acid promoter operably linked to the second nucleic acid, and wherein the second nucleic acid encodes an sgRNA capable of binding the target sequence.

28. The method of claim 27, wherein at least one of the first nucleic acid promoter or the second nucleic acid promoter comprises a sequence with at least 90% identity to a sequence selected from the group consisting of SEQ ID NO: 78 (MzU3.8), SEQ ID NO: 79 (ZmU3), SEQ ID NO: 82 (ZmU3P1), SEQ ID NO: 84 (ZmU3P2), and SEQ ID NO: 86 (MzU3.8P).

29. The method of claim 27, wherein the second nucleic acid comprises a sequence with at least 90% identity to a sequence selected from the group consisting of SEQ ID NO: 95 (ZmU3P1:sgRNA_GWDe24b), SEQ ID NO: 96 (ZmU3P2:sgRNA_GWDe24b), SEQ ID NO: 97 (ZmU3.8P:sgRNA_GWDe24b), SEQ ID NO: 98 (ZmU3P2:sgRNA_GWDe24c), SEQ ID NO: 99 (ZmU3P2:sgRNA_GWDe25a), and SEQ ID NO: 100 (ZmU3P2:sgRNA_GWDe1a).

30. The method of claim 14 further comprising processing the homozygous plant with one or more procedure selected from harvesting, bailing, shredding, drying, fermenting, hydrolyzing with chemicals, hydrolyzing with exogenous enzymes, and combining with plant biomass.

31. The method of claim 14 further comprising preparing an animal feed by performing on the homozygous plant at least one procedure selected from the group consisting of harvesting, bailing, shredding, drying, ensiling, pelletizing, combining with a source of edible fiber, and combining with plant biomass.

32. A method of preparing animal feed comprising processing a genetically engineered plant comprising a nucleic acid encoding a restricting enzyme capable of cutting a target sequence, wherein the target sequence is in an endogenous gene encoding a Glucan Water Dikinase, wherein upon the expression of the nucleic acid, the genetically engineered plant has an altered level of vegetative starch compared to the level of vegetative starch in a non-genetically engineered plant, and processing includes at least one of operation selected from the group consisting of harvesting, bailing, grinding, milling, chopping, size reducing, crushing, extracting a component from the feedstock, purifying a component or portion of the feedstock, and extracting or purifying starch.

33. The method of claim 32, wherein the restricting enzyme is selected from the group consisting of a meganuclease, a zinc-finger nuclease, and a TAL effector nuclease.

34. The method of claim 33, wherein the meganuaclease is selected from the group consisting of I-CreI, I-Dmol, I-SceI, E-Dmel, and DmoCre.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0020] The following detailed description of embodiments of the present invention will be better understood when read in conjunction with the appended drawings. For the purpose of illustration, there are shown in the drawings particular embodiments. It is understood, however, that the invention is not limited to the precise arrangements and instrumentalities shown. In the drawings:

[0021] FIG. 1 illustrates the vector pAG4715 for expressing meganuclease.

[0022] FIG. 2 illustrates the vector pAG4716 for expressing meganuclease.

[0023] FIG. 3 illustrates PCR detection of mutants.

[0024] FIG. 4 illustrates a chart depicting starch content (mg starch per gram dry weight) across populations of mutant homozygous, heterozygous and hemizygous corn plants produced by using vectors pAG4715 and pAG4716. Lines 195, 20, 19, 18, 9 and 6 are control plants.

[0025] FIG. 5 illustrates starch content in green tissue of gwd knock-out corn mutants: bar 1 is wild type (WT) plant, bar 2 is M17, bar 3 is M18, bar 4 is M1, bar 5 is M20, bar 6 is M13/M12, bar 7 is M9, bar 8 is M7/M11, bar 9 is M4/M14, bar 10 is M11/M12, bar 11 is M15, bar 12 is M14, bar 13 is M11, bar 14 is M11/M10 and bar 15 is M13.

[0026] FIG. 6 illustrates starch staining in gwd knock-out (GWDko) meganuclease cobs.

[0027] FIG. 7 illustrates the vector pAG4800 for expressing ZmCas9.

[0028] FIG. 8 illustrates the vector pAG4804 for expressing sgRNA scaffold and ZmCas9.

[0029] FIG. 9 illustrates starch accumulation in the pAG4804 maize events.

[0030] FIG. 10 illustrates starch accumulation in the pAG4806 maize events.

[0031] FIG. 11 illustrates a schematic drawing of selfing and outcrossing of a targeted mutation M20 derived from the maize event 4716_164.

[0032] FIG. 12 illustrates genotyping of T1 progeny from the selfed T0 4716_164 M20 plant.

[0033] FIG. 13 illustrates genotyping of T1 progeny from the outcrossed T0 4716_164 M20 plant.

[0034] FIG. 14 illustrates genotyping of T1 progeny from the outcrossed 4716_164 M20 plant.

DETAILED DESCRIPTION

[0035] Certain terminology is used in the following description for convenience only and is not limiting.

[0036] Engineered nucleic acid sequence, engineered polynucleotide, engineered oligonucleotide, engineered DNA, or engineered RNA as used herein refers to a nucleic acid, polynucleotide, oligonucleotide, DNA, or RNA that differs from one found in nature by having a different sequence than one found in nature or a chemical modification not found in nature. The engineered nucleic acid sequence, engineered polynucleotide, engineered oligonucleotide, engineered DNA, or engineered RNA may be a synthetic nucleic acid sequence, synthetic polynucleotide, synthetic oligonucleotide, synthetic DNA, or synthetic RNA. The definition of engineered nucleic acid includes but is not limited to a DNA sequence created using biotechnology tools. Such tools include but are not limited to recombinant DNA technology, chemical synthesis, or directed use of nucleases (so called genome editing or gene optimizing technologies).

[0037] Endogenous nucleic acid as used herein refers to a nucleic acid, polynucleotide, oligonucleotide, DNA, or RNA naturally occurring in the organism or the genome. An endogenous nucleic acid may be an endogenous gene.

[0038] Altered protein as used herein refers to a protein, polypeptide, oligopeptide or peptide that contains at least one amino acid change, or deletion compared to the amino acid sequence contained in a naturally occurring organism, e.g., a parent organism. An altered protein may retain or lack the biological activity of the original sequence.

[0039] As used herein, operably linked refers to the association of two or more biomolecules in a configuration relative to one another such that the function of the biomolecules can be performed. In relation to two or more nucleotide sequences, operably linked refers to the association of the nucleic acid sequences in a configuration relative to one another such that the function of the sequences can be performed. For example, a nucleotide sequence encoding a presequence or secretory leader is operably linked to a nucleotide sequence for a polypeptide if it is expressed as a preprotein that participates in the secretion of the polypeptide; a promoter or enhancer sequence is operably linked to a coding sequence if it affects the transcription of the coding sequence; and a nucleic acid ribosome binding site is operably linked to a coding sequence if it is positioned so as to facilitate binding of the ribosome to the nucleic acid.

[0040] As used herein, genetic background is defined as the sum of all genes, or a collection of specific genes (e.g., all genes but for an engineered genetic modification) in a plant. Plants of the same species may be referred to as plants having the same genes or the same genetic background. A genetically engineered plant may include an engineered nucleic acid or polynucleotide described herein but otherwise have the same genes as non-genetically engineered plant of the same genetic background.

[0041] The words a and one, as used in the claims and in the corresponding portions of the specification, are defined as including one or more of the referenced item unless specifically stated otherwise. This terminology includes the words above specifically mentioned, derivatives thereof, and words of similar import. The phrase at least one followed by a list of two or more items, such as A, B, or C, means any individual one of A, B or C as well as any combination thereof.

[0042] An embodiment comprises a genetically engineered plant comprising an engineered nucleic acid encoding an altered Glucan Water Dikinase. The genetically engineered plant may have an elevated level of starch in comparison to a plant of the same genetic background but comprising a wild type (wt) GWD. The activity of the altered GWD may be reduced in comparison to wild type (wt) GWD included in a plant of the same genetic background. The level of reduction may be 20, 30, 40, 50, 60, 70, 80, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% based on the level of wt GWD. Activity of GWD may be tested by monitoring starch content in plants, for example, by using Fourier Transform Near-infrared (FT-NIR) Technique as described in Example 3 herein. The altered GWD may be inactive. Increased levels of starch indicate reduced GWD activity.

[0043] In an embodiment, the engineered nucleic acid in the genetically engineered plant may comprise an endogenous nucleic acid that includes at least one allele of a gwd gene encoding a GWD protein but having one or more modifications in comparison to the wild type plant. The modifications may be made made by genetic engineering of the plant or its ancestors. The endogenous nucleic acid may be one or more allele of the gwd gene in the engineered plant. The modifications may be in the gwd coding sequences. The endogenous nucleic acid may comprise, consist essentially of, or consist of a sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100% identity to a reference sequence selected from SEQ ID NO: 1 (Zm GWD coding sequence) or SEQ ID NO: 2 (Sb GWD coding sequence). The engineered nucleic acid may include at least one mutation relative to the endogenous nucleic acid. A mutation may include an insertion of one or more nucleotides in comparison to the endogenous nucleic acid. A mutation may include a deletion of nucleotides in comparison to the native nucleic acid. A mutation may include a substitution of one or more nucleotides in comparison to the endogenous nucleic acid. A mutation may be a combination of several mutations. The at least one mutation may be within a target sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100% identity to a reference sequence selected from SEQ ID NO: 1 (Zm GWD coding sequence), SEQ ID NO: 2 (Sb GWD coding sequence), SEQ ID NO: 3 (Zm GWD Exon 24+introns), SEQ ID NO; 4 (SbGWD Exon 24+ introns), SEQ ID NO: 91 (GWDe1a), SEQ ID NO: 92 (GWDe24b), SEQ ID NO: 93 (GWDe24c), and SEQ ID NO: 94 (GWDe25a), SEQ ID NO: 182 (ZmGWD Exon 24), SEQ ID NO: 183 (Sb GWD Exon 24), SEQ ID NO: 184 (SbGWD Exon 7) and SEQ ID NO: 189 (Zm GWD Exon 25).

[0044] In an embodiment, the engineered nucleic acid in the genetically engineered plant may be an endogenous nucleic acid that includes at least one allele of a gwd gene encoding a GWD protein but having one or more modifications made by genetic engineering of the plant or its ancestors. The endogenous nucleic acid may be one or more allele of the gwd gene in the engineered plant. The modifications may be in the gwd coding sequences. The endogenous nucleic acid may comprise, consist essentially of, or consist of a sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100% identity to a reference sequence selected from SEQ ID NO: 1 (Zm GWD coding sequence) or SEQ ID NO: 2 (Sb GWD coding sequence). The engineered nucleic acid may include at least one mutation relative to the endogenous nucleic acid. A mutation may include an insertion of one or more nucleotides in comparison to the endogenous nucleic acid. A mutation may include a deletion of nucleotides in comparison to the native nucleic acid. A mutation may include a substitution of one or more nucleotides in comparison to the endogenous nucleic acid. A mutation may be a combination of several mutations. The at least one mutation may be within a target sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100% identity to a reference sequence selected from SEQ ID NO: 1 (Zm GWD coding sequence), SEQ ID NO: 2 (Sb GWD coding sequence), SEQ ID NO: 3 (Zm GWD Exon 24+ introns), SEQ ID NO; 4 (SbGWD Exon 24+ introns), SEQ ID NO: 91 (GWDela), SEQ ID NO: 92 (GWDe24b), SEQ ID NO: 93 (GWDe24c), and SEQ ID NO: 94 (GWDe25a), SEQ ID NO: 182 (ZmGWD Exon 24), SEQ ID NO: 183 (Sb GWD Exon 24), SEQ ID NO: 184 (SbGWD Exon 7) and SEQ ID NO: 189 (Zm GWD Exon 25).

[0045] In an embodiment, the engineered nucleic acid in the genetically engineered plant comprises a modified sequence of Exon 24 of the maize gwd gene. The engineered nucleic acid may comprise, consist essentially of, or consist of a polynucleotide having a sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a reference sequence selected from SEQ ID NOS: 12-40, 114-118, 119-120 and 131-146, which comprise mutations in the maize gwd gene.

[0046] In an embodiment, the engineered nucleic acid in the genetically engineered plant may comprise a modified sequence having one or more modifications within a region of the wild type Zm GWD gene (SEQ ID NO: 1) in the position from 3030 nucleotide (nt) to 3243 nt. In an embodiment, the engineered nucleic acid in the genetically engineered plant may comprise a modified sequence having one or more modifications within a region of the wild type Zm GWD gene (SEQ ID NO: 1) in the position from 3157 nt to 3213 nt. In an embodiment, the engineered nucleic acid in the genetically engineered plant may comprise a modified sequence having one or more modifications within a region of the wild type Zm GWD gene Exon 24 (SEQ ID NO: 3) in the position from 81 nt to 160 nt.

[0047] In an embodiment, the Zm GWD gene in the genetically engineered plant may comprise a modified sequence with changes in the sequence relative to wild type Zm GWD (SEQ ID NO: 1) in one of SEQ ID NOS: 12-40, 114-118, 119-120 and 131-146. The sequence of Zm GWD with the changes outside of the positions where the changes are located may have at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100% identity to the corresponding regions of SEQ ID NO: 1. The changes may be the same or different from one of SEQ ID NOS: 12-40, 114-118, 119-120 and 131-146.

[0048] In an embodiment, the engineered nucleic acid in the genetically engineered plant may comprise a modified sequence of Exon 24 of the sorghum gwd gene. The engineered nucleic acid may comprise, consist essentially of, or consist of a polynucleotide having a sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a reference sequence selected from SEQ ID NO: 106 (Sb4715_1 (WT+ins)_Exon 24), and SEQ ID NO: 107 (Sb4715_2 (WT+del)_Exon 24), which are mutations in Exon 24 in the sorghum gwd gene. In an embodiment, the engineered nucleic acid in the genetically engineered plant may comprise a modified sequence having one or more modifications within a region of the wild type Sb GWD gene (SEQ ID NO: 2) in the position from 3030 nt to 3243 nt. The engineered nucleic acid in the genetically engineered plant may comprise a modified sequence having one or more modifications within a region of the wild type Sb GWD gene (SEQ ID NO: 2) in the position from 736 nt to 969 nt. The altered GWD may be encoded by any one of the engineered nucleic acids herein.

[0049] In an embodiment, a genetically engineered plant may comprise an altered Zea mays GWD (Zm GWD). The altered ZmGWD may comprise, consist essentially of, or consist of an amino acid sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100% identity to a reference sequence selected from SEQ ID NOS: 45-73 (Zm GWD mutant proteins M1-M29), 121-125 (Zm GWD mutant proteins M32-M36), 126-127 (Zm GWD mutant proteins M38-M39) and 147-162 (Zm GWD mutant proteins M40-M55).

[0050] In an embodiment, the altered ZmGWD protein in the genetically engineered plant may comprise a modified sequence having one or more modifications within a region of the wild type Zm GWD protein (SEQ ID NO: 43) in the positions from 1040 amino acid (aa) to 1120 aa. The altered ZmGWD protein in the genetically engineered plant may comprise a modified sequence having one or more modifications within a region of the wild type Zm GWD protein (SEQ ID NO: 43) in the positions from 1054 aa to 1081 aa. The altered ZmGWD protein in the genetically engineered plant may comprise a modified sequence having one or more modifications within a region of the wild type Zm GWD protein (SEQ ID NO: 43) in the positions from 1011 aa to 1057 aa. The altered ZmGWD protein in the genetically engineered plant may comprise a modified sequence having one or more modifications within a region of the wild type Zm GWD protein (SEQ ID NO: 43) in the positions from 1082 aa to 1116 aa.

[0051] In an embodiment, the Zm GWD protein in the genetically engineered plant may comprise a modified sequence with changes in the sequence relative to wild type Zm GWD (SEQ ID NO: 43) in one of SEQ ID NOS: 45-73 (Zm GWD mutant proteins M1-M29), 121-125 (Zm GWD mutant proteins M32-M36), 126-127 (Zm GWD mutant proteins M38-M39) and 147-162 (Zm GWD mutant proteins M40-M55). The sequence of Zm GWD with the changes outside of the positions where the changes are located may have at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100% identity to the corresponding regions of SEQ ID NO: 43. The changes may be the same or different from one of SEQ ID NOS: 45-73 (Zm GWD mutant proteins M1-M29), 121-125 (Zm GWD mutant proteins M32-M36), 126-127 (Zm GWD mutant proteins M38-M39) and 147-162 (Zm GWD mutant proteins M40-M55).

[0052] In an embodiment, a genetically engineered plant may comprise an altered Sorghum bicolor GWD (Sb GWD). The altered Sb GWD may comprise, consist essentially of, or consist of an amino acid sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100% identity to a reference sequence selected from SEQ ID NO: 194(Sb GWD mutant protein Sb4715_1WT+ins) and SEQ ID NO: 195 (Sb GWD mutant protein Sb4715_2 WT+del). Nucleic acids, nucleotide sequences proteins or amino acid sequences herein can be isolated, purified, synthesized chemically, or produced through recombinant DNA technology. All of these methods are well known in the art.

[0053] In an embodiment, the genetically engineered plant may be any type of plant. The genetically engineered plant may be but is not limited to a monocotyledonous plant, a dicotyledonous plant, a C4 plant, a C3 plant, corn, soybean, rice, sugar cane, sugar beet, sorghum, switchgrass, miscanthus, eucalyptus, wheat, alfalfa, willow, or poplar. The genetically engineered plant may be derived from an energy crop plant, a forage crop plant, or a food crop plant. The energy crop plant may be a corn plant, a switchgrass plant, a sorghum plant, a poplar plant, or a miscanthus plant. The forage crop plant may be a corn plant, an alfalfa plant, a sorghum plant or a soybean plant. The food crop plant may be a corn plant, a wheat plant, a soybean plant, a rice plant, or a tomato plant.

[0054] The genetically engineered plant may be a transgenic plant or a mutant plant. The genetically engineered plant may be a progeny of a transgenic plant or a mutant plant, or a descendant of a transgenic plant or a mutant plant.

[0055] The genetically engineered plant may be a conventional mutant having one or more mutations in a nucleic acid sequence of a gene encoding GWD that result in inhibited expression of the GWD or reduced activity of GWD. The mutations may be deletions, insertions or substitutions of nucleic acids in a sequence of the GWD encoding gene. The conventional mutant may have an altered level of vegetative starch compared to a non-mutant plant of the same genetic background but expressing wild type GWD.

[0056] As used herein, the genetically engineered plant may refer to a whole transgenic plant or mutant plant or a part thereof. The part may be but is not limited to one or more of leaves, stems, flowers, buds, petals, ovaries, fruits, or seeds. The part may be callus from a transgenic plant or a mutant plant. A genetically engineered plant may be regenerated from parts of a transgenic plant or a mutant plant or plants. A genetically engineered plant may be a product of sexual crossing of a first transgenic plant and a second transgenic plant or a non-transgenic plant where the product plant retains an engineered nucleic acid introduced to the first transgenic plant. A genetically engineered plant may be a product of sexual crossing of a first mutant plant and a second non-mutant plant where the product plant retains a mutation introduced to the first mutant plant. The transgenic plant or the mutant plant may be any one of the transgenic plants or mutant plants described herein.

[0057] In an embodiment, a method for genetically engineering a plant that includes an altered Glucan Water Dikinase is provided. The method may include contacting at least one plant cell that comprises a target sequence in an endogenous gene encoding a Glucan Water Dikinase with a vector. The vector may include a first nucleic acid encoding a nuclease capable of inducing a single-strand break or a double-strand break at the target sequence. The vector may be introduced by transforming or otherwise genetically engineering a plant. Transforming may be Agrobacterium-mediated transformation using a vector that includes a first nucleic acid encoding a nuclease. The nuclease may cleave the target sequence as described previously (Puchta et al. 1993; Wright et al. 2005; Wehrkamp-Richter et al. 2009; Cong et al., 2013; Belhaj et al., 2013, all of which are incorporated herein by reference as if fully set forth). The nuclease may be but is not limited to a meganuclease, Cas9 nuclease, a zinc finger nuclease, or a transcription activator-like effector nuclease.

[0058] As stated, the nuclease may be a meganuclease. Meganucleases may introduce single stranded or double stranded DNA breaks and have recognition sites ranging between 14 to 40 nucleotides in length providing good specificity. For use of meganucleases for targeted modification, see Rosen et al., 2006; Wehrkamp-Richter et al. 2009; Djukanovic et al., 2013, all of which are incorporated herein by reference as if fully set forth. The meganuclease may be a LAGLIDADG homing endonuclease (LHE). LAGLIDADG homing endonucleases (LHEs) are native gene-targeting proteins with their coding sequences found in introns or inteins. See Arnould et al., 2011, which is incorporated herein by reference as if fully set forth. The meganuclease may be a I-CreI homing endonuclease. As used herein, the I-Crel homing endonuclease is a meganuclease naturally occurring in chloroplasts of Chlamydomonas reinhardtii, and is a well characterized protein containing a single sequence motif important for nuclease enzymatic activity. See Heath et al., 1997, which is incorporated herein by reference as if fully set forth. The I-CreI endonuclease is suitable for protein engineering and was used for targeted genome modifications in several species including plants. See Rosen et al., 2006; Arnould et al., 2007; Djukanovic et al., 2013, all of which are incorporated herein by reference as if fully set forth. The meganuclease may be I-Dmol, I-SceI, E-Dmel or DmoCre. Other meganucleases may be used.

[0059] The meganuclease may be encoded by a sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a reference sequence selected from the group consisting of SEQ ID NO: 108 (4715_meganuclease) and SEQ ID NO: 109 (4716_meganuclease).

[0060] In an embodiment, the nuclease may be a Cas9 nuclease. Cas9 nuclease is the nuclease used in the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) systems (Cong et al., 2013; Belhaj et al., 2013, both of which are incorporated herein by reference as if fully set forth. The CRISPR/Cas9 is the genome editing technology that due to its low cost, high efficiency and relative simplicity to engineer has a potential of becoming a technology of choice for genome editing in various species, but has not been demonstrated to work in multi-cellular plants by using stable transformation. The CRISPR/Cas9 system may include a Cas9 nuclease and a single guide RNA (sg RNA). The Cas9 nuclease herein may be encoded with a nucleic acid with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a reference sequence of SEQ ID NO: 74 (Cas9 nuclease) or SEQ ID NO: 75 (ZmCas9). The nuclease may have affinity for a sequence that enables the nuclease to cleave the target sequence, or it may be guided to the target sequence by using an sgRNA. The vector herein may further include a second nucleic acid sequence encoding an sgRNA. The targeted modification of the endogenous gene may be made by expressing the Cas9 and sgRNA in a plant cell. The sgRNA chimera molecule may contain an untranslated CRISPR RNA (crRNA), a 20 bp spacer sequence complementary to the target genomic DNA sequence with a 3 bp protospacer-adjacent motif (PAM) sequence (Jinek et al., 2012, which is incorporated herein by reference as if fully set forth). The Cas9 nuclease may be expressed from PPDK, CaMV 35S, Actin, or Ubiquitin promoters in plants, such as Arabidopsis, corn, tobacco, rice, wheat, and sorghum. The sgRNAs may be expressed from primarily RNA Polymerase III promoters U6 or U3 and from RNA polymerase II promoter CaMV E35S (Belhaj et al., 2013; Upadhyay et al., 2014, both of which are incorporated by reference herein as if fully set forth). The sgRNAs may be expressed from SEQ ID NO: 78 (MzU3.8), SEQ ID NO: 79 (ZmU3), ZmU3P1 (SEQ ID NO: 82), ZmU3P2 (SEQ ID NO: 84), or ZmU3.8 promoter (SEQ ID NO: 86) described herein. The promoter may have 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to one of SEQ ID NO: 78 (MzU3.8), SEQ ID NO: 79 (ZmU3), ZmU3P1 (SEQ ID NO: 82), ZmU3P2 (SEQ ID NO: 84), or ZmU3.8 promoter (SEQ ID NO: 86). The promoter may have a length equal to 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% of the length in nucleotides of one of SEQ ID NO: 78 (MzU3.8), SEQ ID NO: 79 (ZmU3), ZmU3P1 (SEQ ID NO: 82), ZmU3P2 (SEQ ID NO: 84), or ZmU3.8 promoter (SEQ ID NO: 86). The percent identity of promoters shorter than SEQ ID NO: 78 (MzU3.8), SEQ ID NO: 79 (ZmU3), ZmU3P1 (SEQ ID NO: 82), ZmU3P2 (SEQ ID NO: 84), or ZmU3.8 promoter (SEQ ID NO: 86 may be as set forth above along the length of the shorter promoter. Cas9 nuclease may introduce a single stranded break or double stranded DNA break into an endogenous nucleic acid included in genomic DNA. Subsequently, breaks introduced by Cas9 in genomic DNA may be repaired via two distinct mechanisms NHEJ (non homologous ends joining) and HR (homologous recombination) (Symington and Gautier, 2011, which is incorporated herein by reference as if fully set forth).

[0061] In an embodiment, the nuclease may be a transcription activator-like effector nucleases (TALEN). As used herein, TALENs refer to proteins derived from Xanthomonas. TALENs are customizable fusion proteins comprising an engineered DNA-binding domain of TAL effectors fused to DNA cleavage domains of FokI endonuclease (Boch and Bonas, 2010; Christian et al., 2010; Joung and Sander, 2013; Li et al., 2011, all of which are incorporated herein by reference as if fully set forth). These chimeric proteins may work in pairs of two monomers for targeting FokI endonuclease to a specific DNA sequence within a genome for DNA cleavage. The TAL DNA-binding domain may be modified to recognize different sequences (Cermak et al., 2011, which is incorporated herein by reference as if fully set forth).

[0062] In an embodiment, the nuclease may be a zinc-finger nuclease. (Wright et al. 2005; Shukla et al., 2009, both of which are incorporated herein by reference as if fully set forth).

[0063] In an embodiment, the nuclease may be any other nuclease suitable for targeted modification of the target sequence.

[0064] The target sequence may be a target gene. The target gene may be an endogenous gene that is native to the plant. The target sequence may be a gwd gene of a plant The target sequence may be contained within SEQ ID NO: 1 (Zm GWD coding sequence) or SEQ ID NO: 2 (Sb GWD coding sequence). The target sequence may be any nucleic acid sequence included in an exon of an endogenous nucleic acid encoding GWD. The target sequence may be included in an exon of an endogenous nucleic acid encoding a maize GWD. The target sequence may be included in an exon of an endogenous nucleic acid encoding a sorghum GWD. The target sequence may be included in Exon, 1, Exon 7, Exon 24, or Exon 25 of an endogenous nucleic acid encoding GWD. The target sequence may be a target sequence for the meganuclease. The target sequence may comprise, consist essentially of, or consist of a sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to SEQ ID NO: 41 (Meganuclease GWD-9/10x.272 target sequence (pAG4715)) or SEQ ID NO: 42 (Meganuclease GWD-7/8x target sequence (pAG4716)). The target sequence may be the target sequence for Cas9 nuclease. The target sequence may comprise, consist essentially of, or consist of a sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to SEQ ID NO: 91 (GWDe1a), SEQ ID NO: 92 (GWDe24b), SEQ ID NO: 93 (GWDe24c), or SEQ ID NO: 94 (GWDe25a). The sgRNA may be capable of binding a target sequence selected from the group consisting of SEQ ID NO: 91 (GWDela), SEQ ID NO: 92 (GWDe24b), SEQ ID NO: 93 (GWDe24c), and SEQ ID NO: 94 (GWDe25a). The target sequence may be any sequence that hybridizes with the sgRNA. The nuclease may have affinity for a sequence that enables the nuclease to cleave the target sequence, or it may be guided to the target sequence by using an sgRNA.

[0065] Once expressed, the nuclease will introduce one stranded or double stranded DNA breaks in the target sequence. For example, nuclease may delete a short segment that then may be partially repaired by the cell's DNA repair mechanisms, but leaving a lesion within the target sequence. The repaired target sequence may include an alteration. The alteration may include a mutation. The mutation may be at least one of an insertion, a deletion, or a substitution of one or more nucleotides in the target sequence. The mutation may be a null mutation. As used herein, the term null mutation refers to a mutation in a gene that leads to its not being transcribed into RNA or translated into a functional protein. Because of the mutation in the target sequence, the native nucleic acid sequence may encode an altered GWD. The activity of the altered GWD may be reduced. The level of reduction may be 20, 30, 40, 50, 60, 70, 80, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% of the activity level of wild type GWD and may be tested by monitoring starch content in plants by using Fourier Transform Near-infrared (FT-NIR) Technique as described as described in Example 3 herein. The altered GWD may be inactive. The genetically engineered plant having the alteration or progeny thereof may have an elevated level of starch in comparison to a non-genetically engineered plant of the same genetic background.

[0066] The method may include selecting a plant cell that includes an alteration of the target sequences. The method may include regenerating the plant including the alteration from the plant cell. The genetically engineered plant may be homozygous for the alteration.

[0067] The genetically engineered plant may be heterozygous for the alteration. The genetically engineered plant herein may be heterozygous for the gene that includes the mutation. The gene may include the engineered nucleic acid encoding the altered GWD. The heterozygous plants may include alleles of the endogenous gene that encode a wild type, unaltered, GWD. The heterozygous plant may also include hemizygous plants when at least one allele of the gene encoding GWD is missing. A heterozygous plant may be phenotypically indistinguishable from the wild type plants and may not have elevated levels of starch. To produce homozygous plants with elevated levels of starch, a heterozygous genetically engineered plant may be self-crossed. Progeny may be obtained from such crosses. The progeny may include homozygous, heterozygous and wild type plants. A heterozygous plant may be phenotypically indistinguishable from the wild type plants. The method may include analyzing the progeny for the presence of the alteration and selecting a progeny plant that includes the alteration.

[0068] In an embodiment, the method may further include crossing a heterozygous genetically engineered plant to another genetically engineered plant heterozygous for the same alteration. The method may include selecting a first progeny plant that is homozygous for the alteration. The method may further include crossing the genetically engineered plant to a wild type plant of the same genetic background. Progeny may be obtained from such crosses. The progeny may include heterozygous and wild type plants. The method may include selecting a first progeny plant that is heterozygous for the alteration. The method may further include selfing the first heterozygous progeny plant and selecting a second progeny plant that is homozygous for the alteration.

[0069] A genetically engineered plant herein may be homozygous or heterozygous for the gene that includes the mutation and may include a transgene encoding a nuclease. The transgene encoding the nuclease may be segregated away during the above-described crosses.

[0070] An embodiment comprises a method for producing a genetically engineered plant homozygous for an engineered nucleic acid encoding a protein. The engineered nucleic acid may encode a recessive trait. The recessive trait may include a cleaved endogenous target sequence of a gene. The recessive trait may only be observed in plants that do not contain an unaltered, wild-type, allele of the gene. The method may comprise making an engineered nucleic acid by modifying a sequence of an endogenous nucleic acid. The method may also comprise breeding the recessive trait into other crop lines. The method may comprise maintaining the trait in the crop lines. The method may comprise generating homozygous progeny. The method may include making hybrid seed with a recessive trait.

[0071] An embodiment comprises a plant genetically engineered by any one of methods described herein is provided.

[0072] An embodiment comprises a method of increasing a starch level in a plant. The method may comprise expressing a nucleic acid encoding a meganuclease in a plant. The method may comprise expressing a nucleic acid that encodes a TALEN in a plant. The method may comprise expressing a first nucleic acid that encodes a Cas9 nuclease and a second nucleic acid that encodes a desired guide RNA that target a specific sequence. Expression of the nucleic acid(s) in the plant may alter the function or coding of an endogenous DNA sequence. Expression of the nucleic acid(s) in the plant may alter the activity of GWD and starch metabolism in the plant. The plant may be any transgenic or mutant plant herein. The plant may be a progeny of the transgenic or mutant plant. The nucleic acid(s) may be included in a genetic construct(s). The method may comprise making any genetically engineered plant herein. The genetically engineered plant or its progeny may be the plant, in which starch levels may be increased by the method herein.

[0073] A genetic construct having a nucleic acid encoding a meganuclease that inactivates or inhibits expression of the GWD protein involved in mobilization of starch in a plant in may be expressed at any point in the methods. The nucleic acid may be expressed prior to the step of processing the plant. The nucleic acid may be expressed during the step of processing the plant. The expression may be induced. Upon the expression of the nucleic acid(s), the genetically engineered plant may have an altered level of vegetative starch compared to the level of starch in a non-genetically engineered plant of the same genetic background but lacking the one or more genetic construct.

[0074] Any genetically engineered plant herein may be provided in a method of agricultural processing, a method of preparing animal feed, or a method of feeding an animal. A step of providing the genetically engineered plant may include obtaining it from another party that produced it. A step of providing may include making the genetically engineered plant. The genetically engineered plant may be a transgenic plant or mutant plant. The step of providing may include transforming the plant by contacting the plant with any one of the genetic constructs herein. The step of providing may include stable transformation of the plant by any of the methods described herein, or known methods. The step of providing may include genetically engineering the plant by cleaving a gene encoding a protein involved in starch metabolism at a cleavage site recognized by a nuclease transiently expressed in the plant after contacting the plant with a genetic construct comprising a polynucleotide encoding the nuclease. The step of providing may also include regenerating the plant from a tissue of the genetically engineered plant having an altered level of vegetative starch. The step of providing may include obtaining a progeny of the genetically engineered plant resulted from self-pollination or cross-pollination between the genetically engineered plant and non-genetically engineered plant. The step of providing may include obtaining homozygous progeny. The homozygous progeny may be inbred plants. The homozygous progeny may be hybrid plants. The genetically engineered plant may be used in a variety of subsequent methods or uses. The step of providing may include procuring the genetically engineered plant. The step of providing may include making the genetically engineered plant available for further processing steps. The step of providing may include making the genetically engineered plant available as part of an animal diet.

[0075] In the method of agricultural processing, the genetically engineered plant may be a feedstock engineered with elevated levels of starch and/or expressing one or more polysaccharide degrading enzyme. The feedstock may include any genetically engineered plant herein alone or in combination with other components. The other components may include other plant material. Agricultural processing may include manipulating or converting any agricultural feedstock including the genetically engineered plant for a particular product or use. Agricultural processing may comprise drying the genetically engineered plant. Agricultural processing may comprise fermenting the genetically engineered plant. Agricultural processing may comprise hydrolyzing the genetically engineered plant with one or more an exogenous enzymes to obtain a biochemical product. The exogenous enzymes may be lignin degrading enzymes, cellulose degrading enzymes, or hemicellulose degrading enzymes. The exogenous enzymes may be glycosidases, xylanases, cellulases, endoglucanases, exoglucanases, cellobiohydrolases, -xylosidases, feruloyl esterases, -glucosidases, and amylases. The exogenous enzymes may be purchased from a vendor and may comprise Accellerase 1000, Accellerase 1500, Accelerase TRIO, and Accellerase XY available from Genencor International (Rochester, N.Y.). Exogenous enzymes may comprise Cellic, CTEC, HTEC available from Novozymes (Denmark). The exogenous enzymes may comprise starch degrading enzymes. The exogenous enzymes may comprise an amylase or an invertase. The method of agricultural processing may include simultaneous saccharification and fermentation of soluble sugars to produce ethanol.

[0076] A method of agricultural processing herein may comprise harvesting the genetically engineered plants having elevated levels of starch for use as a feedstock in agricultural processing. The method may include combining the genetically engineered plant with plant biomass. The plant biomass may include non-genetically engineered plants. The plant biomass may be genetically engineered plant biomass. The genetically engineered plant biomass may express polysaccharide degrading enzymes. By combining the genetically engineered plant with the plant biomass that express polysaccharide degrading enzyme, the method herein may not require harsh pretreatments to improve cellulose cell wall accessibility to exogenous enzymes. The methods herein may utilize any methods and compositions for consolidated pretreatment and hydrolysis of plant biomass expressing cell wall degrading enzymes described in U.S. patent application Ser. No. 13/414,627, filed Mar. 7, 2012; and International Patent Application No. PCT/US2012/028132, filed Mar. 7, 2012, which are incorporated herein by reference as if fully set forth. Plants with altered levels of elevated starch were described International Patent Application No. PCT/US2011/041991, filed Jun. 27, 2011; and U.S. patent application Ser. No. 13/806,654, filed Mar. 19, 2013; and U.S. patent application Ser. No. 13/793,078, filed Mar. 11, 2013, which are incorporated herein by reference as if fully set forth.

[0077] The genetically engineered plant may be provided in a method of preparing animal feed. Preparing animal feed may comprise combining the genetically engineered plant with animal feed stuffs, including but not limited to corn, grain, soybeans, and/or other forage. Preparing animal feed may comprise ensiling the genetically engineered plant to make silage. Preparing animal feed may comprise combining the genetically engineered plant with distillers' grains. Preparing animal feed may comprise pelletizing the genetically engineered plant into feed pellets. Preparing animal feed may comprise combining the genetically engineered plant with a source of edible fiber. Preparing animal feed may comprise combining the genetically engineered plant with a source of protein. Preparing animal feed may comprise combining the genetically engineered plant with one or more carbohydrates as a source of energy. Preparing animal feed may comprise combining the genetically engineered plant with one or more exogenous enzymes described herein.

[0078] A method of agricultural processing or or a method of preparing animal feed may also comprise at least one of the operations of harvesting, baling, grinding, milling, chopping, size reducing, crushing, extracting a component from the feedstock, purifying a component or portion of the feedstock, extracting or purifying starch, hydrolyzing polysaccharides into oligosaccharides or monosaccharides, chemical conversion, or chemical catalysis of the feedstock.

[0079] In an embodiment, animal feed formulations comprising increased levels of starch in vegetative tissues are provided. Animal feed formulations may be used for increasing milk and beef production by feeding animals plant material with increased levels of starch. Easily-fermentable sugars available in a fermentation process may be provided by embodiments herein. Production of biofuels may be enhanced by providing easily-fermentable sugars. Methods of providing easily fermentable sugars and methods of enhancing production of biofuels are provided as embodiments herein. The animal feed formulations may comprise any one or more of the genetically engineered plants herein. The animal feed formulations may comprise the products of a method of preparing animal feed herein.

[0080] Crops with elevated levels of vegetative starch may have a variety of uses and utilities. In an embodiment, biomass from plants that accumulate elevated levels of vegetative starch relative to wild type plants are provided. The biomass may be from any genetically engineered plant herein or its progeny. These plants may have added value as feedstocks for fermentation processes or animal feed applications. For example, in a typical cellulosic process, polysaccharides, such as cellulose and hemicelluloses that are present in the biomass, are hydrolyzed to simple sugars, which may then be fermented to ethanol, butanol, isobutanol, fatty acids, or other hydrocarbons by microorganisms. Because of the recalcitrance of the biomass, the release of the simple sugars from polymers, such as cellulose and hemicelluloses, often requires the use of harsh pretreatment conditions and hydrolysis with relatively expensive mixtures of enzymes. A similar situation occurs in ruminant animals that eat forage, including corn silage, as a nutrient and an energy source. In ruminant animal, the forage is masticated and moves into the rumen, where the fiber polysaccharides, such as cellulose and hemicellulose, are hydrolyzed and fermented by the microorganisms in the rumen flora. These organisms create fatty acids that are absorbed by the animal and metabolized, providing nutrition to the animal. In either ruminant digestion or biofuels processing, any starch that is present in the biomass represents an additional source of readily fermentable sugars (namely, glucose), which are less recalcitrant to hydrolysis and can be released very easily by amylases or mild chemical treatments. As a result, any increase in the amount of starch present in the biomass will simultaneously increase the amount of fermentable sugar that can be recovered. Biomass that contains elevated levels of starch may have greater value in forage applications, where the plant material is fed to livestock or dairy animals. Again, the excess starch present in this material is more easily digested by most animals than is the cellulosic material, providing more energy per unit biomass than biomass with ordinary levels of starch. Embodiments include utilizing a plant as set forth herein for any of these methods.

[0081] Methods herein, including those in the previous paragraph, may include at least one of modifying plants to create genetically engineered plants, growing the genetically engineered plants, harvesting the genetically engineered plants, processing (for example reducing the size of the forage, ensiling, treating with an inoculant, combining with other feed components, or pelleting) them for animal feed applications as one would other forage crops, or fermenting the genetically engineered plants in a manner similar to treatments that are used in cellulosic processing. Cellulosic processing steps used may comprise pretreating and hydrolyzing the polysaccharides into their component sugars by enzymatic or chemical hydrolysis or digestion. Any one step, set of steps, or all the steps set forth in this paragraph may be provided in a method herein.

[0082] An embodiment comprises a genetic construct designed to implement a strategy for modifying levels of vegetative starch in plants. The genetic construct may comprise a first engineered nucleic acid sequence that encodes a nuclease capable of cleaving a target sequence in an endogenous nucleic acid encoding GWD. The first engineered nucleic acid may encode any one of the nucleases described herein. The genetic construct may also include a second engineered nucleic acid sequence encoding an sgRNA. The second engineered nucleic acid may encode any one the sgRNAs described herein. The genetic construct may include a promoter operably linked to the first engineered nucleic acid sequence or the second engineered nucleic acid. The operably linked promoter may allow transcription of the first engineered nucleic acid sequence encoding a nuclease, or the second engineered nucleic acid sequence encoding the sgRNA. Transcription and translation of the first engineered nucleic acid sequence may be referred to as expression of the nuclease. Upon expression, the nuclease may cut the target sequence of the endogenous nucleic acid. The endogenous nucleic acid may encode GWD. Transcription of the second nucleic acid sequence may result in production of an sgRNA that recognizes a target sequence within an endogenous nucleic acid and guides Cas9 nuclease to the target for making a break.

[0083] The genetic construct may include regions encoding nuclear localization signals. As used herein, nuclear localization signals (NLS) refers the short motifs of basic amino acid sequences within nuclear proteins. Transport of certain proteins from cytoplasm into the nucleolus to perform their specific functions occurs through the nuclear envelope and involves nuclear pore complex (NPC) (Wagner et al., 1990, which is incorporated herein by reference as if fully set forth). In this process, nuclear localization signals (NLS) play an important role as they are thought to be recognized by NPC receptors to subsequently translocate proteins through the nuclear pore complex. The NLSs fall into one of several defined categories (Garcia-Bustos et al., 1991, which is incorporated herein by reference as if fully set forth). The NLS may be the SV40 NLS from simian virus 40 large T antigen, which has been used intensively in experiments for targeted genome modifications due to its activity in various organisms, including plants (Kalderon et al., 1984; Raikhel, 1992, both of which are incorporated herein by reference as if fully set forth). The SV40 NLS may be encoded by a nucleic acid sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a reference sequence of SEQ ID NO: 163. The SV NLS may comprise, consist essentially of, or consist of an amino acid sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a reference sequence of SEQ ID NO: 196. The NLS may be plant specific NLS sequences. Plant specific NLS sequences were also described, for example, in maize regulatory proteins opaque-2 and R (Varagona et al, 1992; Shieh et al, 1993, both of which are incorporated herein by reference as if fully set forth). The plant specific NLS may be encoded by a nucleic acid sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a reference sequence selected from the group of SEQ ID NOS: 164 (NLS1), 165 (NLS3), 166 (NLS4), 167 (NLSS), and 168 (NLS6). The plant specific NLS sequence may comprise, consist essentially of, or consist of an amino acid sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a reference sequence selected from the group of SEQ ID NOS: 128 (NLS1), 129 (NLS3), 130 (NLS4), 169 (NLSS), and 170 (NLS6). The NLS sequence may be a derivative NLS sequence. The NLS sequences or their derivatives may be used to target meganucleases, ZFNs, TALENs, or Cas9 proteins into plant nucleus for targeted genome modification. One or more NLS sequences may be fused with an amino acid sequence of the nuclease.

[0084] The genetic construct may further include one or more regulatory sequences (also referred to as a regulatory element) operably connected to the nucleic acid encoding the nuclease. The promoter may be any kind of promoter. The promoter may be an inducible promoter. The promoter may be a constitutive promoter. The promoter may be an inducible promoter, which initiates transcription of the nucleic acid encoding the nuclease only when exposed to a particular chemical or environmental stimulus. Examples of inducible promoters include but are not limited to alcohol inducible promoters, tetracycline inducible promoters, steroid inducible promoters, or hormone inducible promoters. The promoter may be a constitutive promoter, which provides transcription of the nucleic acids or polynucleotide sequences throughout the plant in most cells, tissues, and organs, and during many but not necessarily all stages of development. The promoter may be specific to a particular developmental stage, organ, or tissue. A tissue specific promoter may be capable of initiating transcription in a particular plant tissue. Plant tissue that may be targeted by a tissue specific promoter may be but is not limited to a stem, leaves, trichomes, anthers, or seed. A constitutive promoter herein may be the rice Ubiquitin 3 promoter (OsUbi3P) or the maize ubiquitin promoter (ZmUbi1). Other known constitutive promoters may be part of the genetic construct herein, and include but are not limited to Cauliflower Mosaic Virus (CAMV) 35S promoter, the Cestrum Yellow Leaf Curling Virus promoter (CMP) or the CMP short version (CMPS), the Rubisco small subunit promoter, the rice actin promoter (OsAct1P), and the maize phosphoenolpyruvate carboxylase promoter (ZmPepCP). The promoter may be a synthetic nucleic acid promoter from maize Zea mays. The synthetic nucleic acid promoter from maize may comprise, consist essentially of, or consist of a sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a reference sequence selected from the group consisting of: SEQ ID NO: 78 (MzU3.8), SEQ ID NO: 79 (ZmU3), ZmU3P1 (SEQ ID NO: 82), ZmU3P2 (SEQ ID NO: 84), or ZmU3.8 promoter (SEQ ID NO: 86). The synthetic nucleic acid promoter may have a length equal to 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% of the length in nucleotides of one of SEQ ID NO: 78 (MzU3.8), SEQ ID NO: 79 (ZmU3), ZmU3P1 (SEQ ID NO: 82), ZmU3P2 (SEQ ID NO: 84), or ZmU3.8 promoter (SEQ ID NO: 86). The percent identity of promoters shorter than SEQ ID NO: 78 (MzU3.8), SEQ ID NO: 79 (ZmU3), ZmU3P1 (SEQ ID NO: 82), ZmU3P2 (SEQ ID NO: 84), or ZmU3.8 promoter (SEQ ID NO: 86 may be as set forth above along the length of the shorter promoter. An embodiment comprises any one of the synthetic nucleic acid promoters described herein. The synthetic nucleic acid promoter may be operably connected with the first engineered nucleic acid or the second engineered nucleic acid molecule and may transcriptionally activate the first or the second engineered nucleic acid. As a result of transcriptional activation, the first or the second engineered nucleic acid may be expressed constitutively in a plant.

[0085] A regulatory element in a genetic construct herein may be a terminator. A terminator is capable of terminating transcription. A terminator sequence may be included at the 3 end of a transcriptional unit of the expression cassette. The transcriptional unit may encode the nuclease. The terminator may be derived from a terminator found in a variety of plant genes. The terminator may be a terminator sequence from the nopaline synthase (NOS) or octopine synthase (OCS) genes of Agrobacterium tumefaciens. The terminator may be the S. pyogenes Cas9 terminator (SEQ ID NO: 88). The terminator may be the ZmU3T terminator (SEQ ID NO: 89). The terminator sequence may be the CaMV 35S terminator from CaMV, or any of the 3UTR sequences shown to terminate the transgene transcription in plants. For example, the terminator may be the maize PepC terminator (3UTR). The genetic construct may be included in a vector. The genetic construct may be integrated into a genome of the genetically engineered plant. The genetic construct may be transiently expressed in the genetically engineered plant.

[0086] The genetic construct may be used for transformation of a plant. The genetic construct may be used for Agrobacterium-mediated transformation of a plant. The genetic construct may be used for transforming a plant by any known methods, for example, particle bombardment or direct DNA uptake. The genetic construct may be cloned and included into a vector.

[0087] An embodiment includes a vector comprising a genetic construct herein and appropriate for genetically engineering a plant. The vector may be an intermediate vector. The vector may be a transformation vector. Vectors incorporating a genetic construct herein may also include additional genetic elements such as multiple cloning sites to facilitate molecular cloning and one or more selectable markers to facilitate selection. A selectable marker that may be included in a vector may be a phosphomannose isomerase (PMI) gene from Escherichia coli, which confers to the transformed cell the ability to utilize mannose for growth. Selectable markers that may be included in a vector include but are not limited to a neomycin phosphotransferase (npt) gene, conferring resistance to kanamycin, a hygromycin phosphotransferase (hpt) gene, conferring resistance to hygromycin, or an enolpyruvylshikimate-3-phosphate synthase gene, conferring resistance to glyphosate. The vector may be any vector described in U.S. application Ser. No. 13/793,078, filed Mar. 11, 2013, which is incorporated herein by reference as if fully set forth. The vector may include a genetic construct encoding any one of the nucleases described herein. The vector may comprise a nucleic acid sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a reference sequence of SEQ ID NO: 108 (meganuclease 4715) or SEQ ID NO: 109 (meganuclease 4716). The vector may comprise a nucleic acid sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a reference sequence of SEQ ID NO: 75 (Zm Cas9). The vector may comprise a sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a reference sequence selected from the group consisting of: SEQ ID NO: 95 (ZmU3P1:sgRNA_GWDe24b), SEQ ID NO: 96 (ZmU3P2:sgRNA_GWDe24b), SEQ ID NO: 97 (ZmU3.8P:sgRNA_GWDe24b), SEQ ID NO: 98 (ZmU3P2:sgRNA_GWDe24c), SEQ ID NO: 99 (ZmU3P2:sgRNA_GWDe25a) and SEQ ID NO: 100 (ZmU3P2:sgRNA_GWDe1a). The vector or the genetic construct described herein may include an engineered nucleic acid. The vector may be pAG4715 (FIG. 1), pAG4716 (FIG. 2), or a modification thereof replacing any one of the annotated landmarks with a counterpart otherwise described herein. Routine vector elements annotated in FIG. 1 or 2 may be replaced by counterparts described herein or known in the art.

[0088] An embodiment includes an engineered nucleic acid comprising, consisting essentially of, or consisting of a sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to SEQ ID NO: 41 (Meganuclease GWD-9/10272 target sequence (pAG4715)) or SEQ ID NO: 42 (Meganuclease GWD-7/8 target sequence (pAG4716)).

[0089] An embodiment includes an engineered nucleic acid sequence comprising, consisting essentially of, or consisting of a sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100% identity to a reference sequence selected from the group consisting of SEQ ID NO: 91 (GWDe1a), SEQ ID NO: 92 (GWDe24b), SEQ ID NO: 93 (GWDe24c), and SEQ ID NO: 94 (GWDe25a).

[0090] An embodiment comprises an engineered nucleic acid having a sequence as set forth in any one of the engineered nucleic acids listed herein or the complement thereof. In an embodiment, an engineered nucleic acid having a sequence that hybridizes to a nucleic acid having the sequence of any nucleic acid listed herein or the complement thereof is provided. In an embodiment, the hybridization conditions are low stringency conditions. In an embodiment, the hybridization conditions are moderate stringency conditions. In an embodiment, the hybridization conditions are high stringency conditions. Examples of hybridization protocols and methods for optimization of hybridization protocols are described in the following books: Molecular Cloning, T. Maniatis, E. F. Fritsch, and J. Sambrook, Cold Spring Harbor Laboratory, 1982; and, Current Protocols in Molecular Biology, F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, K. Struhl, Volume 1, John Wiley & Sons, 2000, which are incorporated by reference in their entirety as if fully set forth. Moderate conditions include the following: filters loaded with DNA samples are pretreated for 2-4 hours at 68 C. in a solution containing 6 citrate buffered saline (SSC; Amresco, Inc., Solon, Ohio.), 0.5% sodium dodecyl sulfate (SDS; Amresco, Inc., Solon, Ohio), 5 Denhardt's solution (Amresco, Inc., Solon, Ohio), and denatured salmon sperm DNA (Invitrogen Life Technologies, Inc. Carlsbad, Calif.). Hybridization is carried in the same solution with the following modifications: 0.01 M EDTA (Amresco, Inc., Solon, Ohio), 100 g/l salmon sperm DNA, and 5-2010.sup.6 cpm .sup.32P-labeled or fluorescently labeled probes. Filters are incubated in hybridization mixture for 16-20 hours and then washed for 15 minutes in a solution containing 2SSC and 0.1% SDS. The wash solution is replaced for a second wash with a solution containing 0.1SSC and 0.5% SDS and incubated an additional 2 hours at 20 C. to 29 C. below Tm (melting temperature in C). Tm =81.5+16.61Log.sub.10(Na+]/(1.0+0.7[Na+]))+0.41(%[G+C])(500/n)PF. [Na+]= Molar concentration of sodium ions. %[G+C]= percent of G+C bases in DNA sequence. N= length of DNA sequence in bases. P= a temperature correction for % mismatched base pairs (1 C. per 1% mismatch). F= correction for formamide concentration (=0.63 C. per 1% formamide). Filters are exposed for development in an imager or by autoradiography. Low stringency conditions refers to hybridization conditions at low temperatures between 37 C. and 60 C., and the second wash with higher [Nat+] (up to 0.825M) and at a temperature 40 C. to 48 C. below Tm. High stringency refers to hybridization conditions at high temperatures over 68 C., and the second wash with [Na+]=0.0165 to 0.0330M at a temperature 5 C. to 10 C. below Tm.

[0091] An embodiment comprises an engineered nucleic acid having a sequence that has at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity along its length to a contiguous portion of a nucleic acid having any one of the sequences set forth herein or the complements thereof. The contiguous portion may be any length up to the entire length of a sequence set forth herein or the complement thereof.

[0092] Determining percent identity of two amino acid sequences or two nucleic acid sequences may include aligning and comparing the amino acid residues or nucleotides at corresponding positions in the two sequences. If all positions in two sequences are occupied by identical amino acid residues or nucleotides then the sequences are said to be 100% identical. Percent identity is measured by the Smith Waterman algorithm (Smith T F, Waterman M S 1981 Identification of Common Molecular Subsequences, J Mol Biol 147:195-197, which is incorporated herein by reference as if fully set forth).

[0093] An embodiment comprises engineered nucleic acids, engineered polynucleotides, or engineered oligonucleotides having a portion of the sequence as set forth in any one of the nucleic acids listed herein or the complement thereof. Theseengineered nucleic acids, engineered polynucleotides, or engineered oligonucleotides may have a length in the range from 10 to full length, 10 to 5000, 10 to 4900, 10 to 4800, 10 to 4700, 10 to 4600, 10 to 4500, 10 to 4400, 10 to 4300, 10 to 4200, 10 to 4100, 10 to 4000, 10 to 3900, 10 to 3800, 10 to 3700, 10 to 3600, 10 to 3500, 10 to 3400, 10 to 3300, 10 to 3200, 10 to 3100, 10 to 3000, 10 to 2900, 10 to 2800, 10 to 2700, 10 to 2600, 10 to 2500, 10 to 2400, 10 to 2300, 10 to 2200, 10 to 2100, 10 to 2000, 10 to 1900, 10 to 1800, 10 to 1700, 10 to 1600, 10 to 1500, 10 to 1400, 10 to 1300, 10 to 1200, 10 to 1100, 10 to 1000, 10 to 900, 10 to 800, 10 to 700, 10 to 600, 10 to 500, 10 to 400, 10 to 300, 10 to 200, 10 to 100, 10 to 90, 10 to 80, 10 to 70, 10 to 60, 10 to 50, 10 to 40, 10 to 35, 10 to 30, 10 to 25, 10 to 20, 10 to 15, or 20 to 30 nucleotides, or 10, 15, 20 or 25 nucleotides. An engineered nucleic acid, engineered polynucleotide, or engineered oligonucleotide having a length within one of the above ranges may have any specific length within the range recited, endpoints inclusive. The recited length of nucleotides may start at any single position within a reference sequence (i.e., any one of the nucleic acids herein) where enough nucleotides follow the single position to accommodate the recited length. In an embodiment, a hybridization probe or primer is 85 to 100%, 90 to 100%, 91 to 100%, 92 to 100%, 93 to 100%, 94 to 100%, 95 to 100%, 96 to 100%, 97 to 100%, 98 to 100%, 99 to 100%, or 100% complementary to a nucleic acid with the same length as the probe or primer and having a sequence chosen from a length of nucleotides corresponding to the probe or primer length within a portion of a sequence as set forth in any one of the nucleic acids listed herein. In an embodiment, a hybridization probe or primer hybridizes along its length to a corresponding length of a nucleic acid having the sequence as set forth in any one of the nucleic acids listed herein. In an embodiment, the hybridization conditions are low stringency. In an embodiment, the hybridization conditions are moderate stringency. In an embodiment, the hybridization conditions are high stringency.

[0094] An embodiment comprises a kit for identifying a modified sequence of an endogenous gene encoding Glucan Water Dikinase in a sample. The kit may comprise a first primer and a second primer. The first primer and the second primer may be capable of amplifying a target sequence included in an endogenous gene encoding Glucan Water Dikinase. The target sequence may include a nucleic acid with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a reference sequence selected from SEQ ID NOS: 1-4, 75, 171-187, 189 and 192. The kit may further comprise one or more component for detecting modifications in the amplified region of the target sequence. The kit may comprise the first primer comprising a nucleic acid sequence selected from SEQ ID NOS: 6, 7, 9, 11, 101, 103, 105, 110, and 111. The kit may comprise the second primer comprising a nucleic acid sequence selected from SEQ ID NOS: 5, 8, 10, 102, and 104. The kit may comprise the first primer comprising the nucleic acid sequence of SEQ ID NO: 6 and the second primer comprising the nucleic sequence of SEQ ID NO: 5. The kit may comprise the first primer comprising the nucleic acid sequence of SEQ ID NO: 7 and the second primer comprising the nucleic acid sequence of SEQ ID NO: 8. The kit may comprise the first primer comprising the nucleic acid sequence of SEQ ID NO: 9 and the second primer comprising the nucleic acid sequence of SEQ ID NO: 10. The kit may comprise the first primer comprising the nucleic acid sequence of SEQ ID NO: 11 and the second primer comprising the nucleic acid sequence of SEQ ID NO: 13. The kit may comprise the first primer comprising the nucleic acid sequence of SEQ ID NO: 110 and the second primer comprising the nucleic acid sequence of SEQ ID NO: 13. The kit may comprise the first primer comprising the nucleic acid sequence of SEQ ID NO: 111 and the second primer comprising the nucleic acid sequence of SEQ ID NO: 112. The kit may comprise the first primer comprising the nucleic acid sequence of SEQ ID NO: 105 and the second primer comprising the nucleic acid sequence of SEQ ID NO: 13. The first primer and the second primer may be capable of amplifying the target sequence to produce an amplified product. The amplified product may comprise a modified target sequence. The modified target sequence may be capable of hybridizing to the sequence of the nucleic acid comprising a sequence selected of SEQ ID NO: 12-40, 106-107, 114-120, 131-146, and 188 under conditions of high stringency. The modified target sequence may be used as a probe for diagnosing the genetically engineered plants having mutations in an endogenous gene encoding the Glucan Water Dikinase. A sample may include any sample in which nucleic acids from plant matter are present. The sample may include any plant matter. The plant matter may derive from a plant or part thereof. The plant material may derive from an animal feed or food.

[0095] An embodiment provides a method of identifying a modified sequence of an endogenous gene encoding a Glucan Water Dikinase in a sample is provided. The method may include contacting a sample with a first primer and a second primer. The method may include amplifying a synthetic polynucleotide comprising a target sequence included in an endogenous gene encoding a Glucan Water Dikinase. The target sequence may be any target sequence included in the endogenous gene encoding the Glucan Water Dikinase described herein. The first primer and the second primer may be capable of amplifying the target sequence to produce an amplified product. The amplified product may be used to determine whether a plant resulted from a sexual crossing or selfing contains one or more modifications in the target sequence and diagnose specific mutants. The length of the amplified product from the sample of the mutant plant may differ from the length of the amplified product from the sample of wild type plant of the same genetic background. The amplified product from the mutant sample may be further used as probe that hybridizes to a synthetic polynucleotide comprising a specific region encoding a mutant protein under conditions of high stringency. The method may include further detecting hybridization of the at least one probe to the specific region of the target sequence.

[0096] Methods of making a genetically engineered plant, methods of increasing starch levels in plants, methods of agricultural processing, methods of preparing animal feed and methods for producing genetically engineered plants homozygous for an engineered nucleic acid that encodes an altered Glucan Water Dikinase may comprise a method of detection herein as part of making genetically engineered plants and/or identifying plants or plant biomass that comprise a genetically engineered nucleic acid herein.

[0097] The following list includes particular embodiments of the present invention. But the list is not limiting and does not exclude alternate embodiments, or embodiments otherwise described herein. Percent identity described in the following embodiments list refers to the identity of the recited sequence along the entire length of the reference sequence.

Embodiments

[0098] 1. A synthetic nucleic acid promoter having a sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a reference sequence selected from the group consisting of: SEQ ID NO: 78 (MzU3.8), SEQ ID NO: 79 (ZmU3), SEQ ID NO: 82 (ZmU3P1), SEQ ID NO: 84 (ZmU3P2) and SEQ ID NO: 86 (MzU3.8P). [0099] 2. A genetic construct comprising a first engineered nucleic acid sequence encoding a Cas9 nuclease, wherein the Cas9 nuclease is capable of cleaving a target sequence in an endogenous nucleic acid encoding Glucan Water Dikinase in a plant. [0100] 3. The genetic construct of embodiment 2, wherein the first synthetic nucleic acid sequence has at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to SEQ ID NO: 74 (Cas9 nuclease) or SEQ ID NO: 75 (ZmCas9). [0101] 4. The genetic construct of one or both embodiments 2 and 3, wherein the first nucleic acid is fused to a polynucleotide sequence encoding at least one nuclear localization signal (NLS). [0102] 5. The genetic construct of any one or more of embodiments 2-4, wherein the polynucleotide sequence encoding the nuclear localization signal is selected from SEQ ID NOS: 163-168. [0103] 6. The genetic construct of any one or more of embodiments 2-5 further comprising a second engineered nucleic acid sequence encoding an sgRNA, and the sgRNA is capable of binding the target sequence. [0104] 7. The genetic construct of embodiments 6, wherein the second engineered nucleic acid comprises a sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a sequence selected from SEQ ID NO: 135 (ZmU3P1:sgRNA_GWDe24b), SEQ ID NO: 136 (ZmU3P2:sgRNA_GWDe24b), SEQ ID NO: 137 (ZmU3.8P:sgRNA_GWDe24b), SEQ ID NO: 138 (ZmU3P2:sgRNA_GWDe24c), SEQ ID NO: 139 (ZmU3P2:sgRNA_GWDe25a) and SEQ ID NO: 40 (ZmU3P2:sgRNA_GWDe1a). [0105] 8. The genetic construct of any one or more of embodiments 2-7, wherein the target sequence has at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a reference sequence selected from the group consisting of SEQ ID NO: 91 (GWDe1a), SEQ ID NO: 92 (GWDe24b), SEQ ID NO: 93 (GWDe24c), and SEQ ID NO: 94 (GWDe25a). [0106] 9. The genetic construct of any one or more of embodiments 2-8 further comprising a first promoter operably linked to the first engineered nucleic acid and a second promoter operably linked to the second engineered nucleic acid. [0107] 10. The genetic construct of embodiment 9, wherein the first promoter or the second promoter is a synthetic nucleic acid promoter of embodiment 1. [0108] 11. The genetic construct of any one or more of embodiments 2-10 further comprising a terminator. [0109] 12. The genetic construct of embodiment 11, wherein the terminator comprises a nucleic acid sequence with at least 90% identity to SEQ ID NO: 88. [0110] 13. A genetic construct comprising an engineered nucleic acid sequence encoding a nuclease, wherein the nuclease is capable of cleaving a target sequence included in an endogenous nucleic acid encoding Glucan Water Dikinase. [0111] 14. The genetic construct of embodiment 13, wherein the nuclease is a meganuclease encoded by a sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a reference sequence selected from the group consisting of SEQ ID N): 164 (4715_meganuclease) and SEQ ID NO: 165 (4716_meganuclease). [0112] 15. The genetic construct of any one or more of embodiments 13-14, wherein the target sequence includes a polynucleotide of SEQ ID NO: 41 (Meganuclease GWD-9/10272) or SEQ ID NO: 42 (Meganucleas3e GWD-7/8. [0113] 16. The genetic construct of any one or more of embodiments 13-15 comprising at least one regulatory element, wherein the regulatory element is selected from a promoter, a terminator, and an enhancer. [0114] 17. A vector comprising a genetic construct of any one or more of embodiments 2-16. [0115] 18. A genetically engineered plant comprising an engineered nucleic acid encoding an altered Glucan Water Dikinase and having an elevated level of starch in comparison to a non-genetically engineered plant of the same genetic background. [0116] 19. The genetically engineered plant of embodiment 18, wherein the activity of the altered Glucan Water Dikinase is reduced compared to the activity of the wild type Glucan Water Dikinase in a non-genetically engineered plant of the same genetic background. [0117] 20. The genetically engineered plant of embodiment 18, wherein the altered Glucan Water Dikinase is inactive. [0118] 21. The genetically engineered plant of any one or more of embodiments 18-20, wherein the engineered nucleic acid is a modified sequence of an endogenous nucleic that is one allele of a gene encoding a Glucan Water Dikinase. [0119] 22. The genetically engineered plant of any one or embodiments 18-21, wherein all alleles of a gene encoding Glucan Water Dikinase in the plant have the sequence of the engineered nucleic acid. [0120] 23. The genetically engineered plant of any one or more of embodiments 18-22, wherein the endogenous nucleic acid includes a sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a reference sequence of SEQ ID NO: SEQ ID NO: 1 (Zm GWD coding sequence) or SEQ ID NO: 2 (Sb GWD coding sequence). [0121] 24. The genetically engineered plant of any one or more of embodiments 18-23, wherein the engineered nucleic acid comprises a mutation selected from at least one of an insertion, a deletion, or substitution of one or more nucleotides in the sequence of the endogenous nucleic acid encoding a wild type GWD. [0122] 25. The genetically engineered plant embodiment 24, wherein the mutation is within a target sequence in the endogenous nucleic acid having at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a reference sequence selected from the group consisting of SEQ ID NO: 3 (Zm GWD Exon 24+ introns), SEQ ID NO; 4 (SbGWD Exon 24+ introns), SEQ ID NO: 182 (ZmGWD Exon 24 no introns), SEQ ID NO: 183 (Sb GWD Exon 24), SEQ ID NO: 184 (SbGWD Exon 7) and SEQ ID NO: 189 (Zm GWD Exon 25). [0123] 26. The genetically engineered plant of any one or more of embodiments 18-25, wherein the mutation is within a target sequence in the endogenous nucleic acid having at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a reference sequence selected from the group consisting of SEQ ID NO: 91 (GWDe1a), SEQ ID NO: 92 (GWDe24b), SEQ ID NO: 93 (GWDe24c), and SEQ ID NO: 94 (GWDe25a). [0124] 27. The genetically engineered plant of any one or more of embodiments 18-26, wherein the engineered nucleic acid comprises a polynucleotide having a sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a reference sequence selected from the group of sequences consisting of SEQ ID NOS: 12-40 (Zm GWD mutations-Exon 24). [0125] 28. The genetically engineered plant of any one or more of embodiments 18-26, wherein the engineered nucleic acid comprises a polynucleotide having a sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a reference sequence selected from the group of sequences consisting of SEQ ID NOS: 114-118, 188, 131-146 (Zm GWD mutations-Exon 24), and 119-120 (Zm GWD mutationsExon 25) . [0126] 29. The genetically engineered plant of any one or more of embodiments 18-25, wherein the engineered nucleic acid comprises a polynucleotide having a sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a reference sequence selected from the group of sequences consisting of SEQ ID NO: 106 (Sb4715_1 (WT+ins)_Exon 24, and SEQ ID NO: 107 (Sb4715_2 (WT+ins)_Exon 24). [0127] 30. The genetically engineered plant of any one or more of embodiments 16-28, wherein the altered Glucan Water Dikinase comprises an amino acid sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a reference sequence selected from the group consisting of SEQ ID NOS: 45-73 (Zm GWD mutant proteins M1-M29). [0128] 31. The genetically engineered plant of any one or more of embodiments 16-25, wherein the altered Glucan Water Dikinase comprises an amino acid sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a reference sequence selected from the group consisting of SEQ ID NOS: 121-125 (Zm GWD mutant proteins M32 -M36), 126-127 (Zm GWD mutant proteins M38-M39) and 147-162 (Zm GWD mutant proteins M40-M55). [0129] 32. The genetically engineered plant of any one or more of embodiments 18-26, wherein the altered Glucan Water Dikinase comprises an amino acid sequence with at least 70, 72, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% identity to a reference sequence selected from SEQ ID NO: 82 (Sb GWD mutant protein Sb4715_1 WT+ ins) or SEQ ID NO: 83 (Sb GWD mutant protein Sb4715_2 WT+ del). [0130] 33. The genetically engineered plant of any one or more of embodiments 18-33, wherein the plant is selected from the group consisting of: a monocotyledonous plant, a dicotyledonous plant, a C4 plant, a C3 plant, tomato, sugar beet, sugar cane, eucalyptus, willow, poplar, corn, sorghum, wheat, alfalfa, soybean, rice, miscanthus, and switchgrass. [0131] 34. A genetically engineered plant comprising a genetic construct of any one or more of embodiments 2-16. [0132] 35. A method for producing a genetically engineered plant comprising:

[0133] transforming a plant cell with a vector of embodiment 17;

[0134] selecting a transformed plant cell that expresses nuclease and comprises an engineered nucleic acid encoding an altered Glucan Water Dikinase; and

[0135] regenerating the genetically engineered plant from the transformed plant cell, wherein the genetically engineered plant or progeny thereof has an elevated level of starch in comparison to a non-genetically engineered plant of the same genetic background. [0136] 36. The method of embodiment 35, wherein the nuclease is a meganuclease. [0137] 37. The method of embodiment 35, wherein the nuclease is a Cas9 nuclease. [0138] 38. A method for genetically engineering a plant comprising an altered Glucan Water Dikinase comprising:

[0139] contacting at least one plant cell comprising a target sequence in an endogenous gene encoding a Glucan Water Dikinase with a vector comprising a first nucleic acid encoding a nuclease capable of inducing a single-strand or double-strand break at the target sequence;

[0140] selecting a plant cell that includes an alteration in the target sequence;

[0141] regenerating a genetically engineered plant including the alteration from the plant cell. [0142] 39. The method of embodiment 38, wherein the genetically engineered plant is homozygous for the alteration. [0143] 40. The method of embodiment 38, wherein the genetically engineered plant is heterozygous for the alteration. [0144] 41. The method of embodiment 40 further comprising selfing the heterozygous genetically engineered plant, or crossing to another genetically engineered plant heterozygous for the same alteration, and selecting a first progeny plant that is homozygous for the alteration. [0145] 42. The method of embodiment 40 further comprising crossing the genetically engineered plant to a wild type plant of the same genetic background and selecting a first progeny plant that is heterozygous for the alteration. [0146] 43. The method of embodiment 42 further comprising selfing the first heterozygous progeny plant and selecting a second progeny plant that is homozygous for the alteration. [0147] 44. The method of any one or more of embodiment 38-43, wherein the alteration is a mutation selected from at least one of an insertion, a deletion, or a substitution of at least one nucleotide in the target sequence. [0148] 45. The method of embodiment 44, wherein the mutation is a null mutation. [0149] 46. The method of any one or more of embodiments 38-44, wherein the genetically engineered plant or progeny thereof has an elevated level of starch in comparison to a non-genetically engineered plant of the same genetic background. [0150] 47. The method of any one or more embodiments 38-46, wherein the nuclease is selected from the group consisting of a meganuclease, Cas9 nuclease, a zinc finger nuclease, and a transcription activator-like effector nuclease. [0151] 48. The method of embodiment 47, wherein the nuclease is the meganuclease and is encoded by a sequence with at least 90% identity to a reference sequence selected from the group consisting of SEQ ID NO: 108 (4715_meganuclease) and SEQ ID NO: 109 (4716_meganuclease). [0152] 49. The method of embodiment 48, wherein the meganuclease is capable of cutting the target sequence that comprises a polynucleotide of SEQ ID NO: 41 (target for 4715_GWD-9/10272) or SEQ ID NO: 42 (target for 4716_3e GWD-7/8276). [0153] 50. The method of embodiment 47, wherein the nuclease is the Cas9 nuclease. [0154] 51. The method of embodiment 50, wherein the Cas9 nuclease is encoded by a nucleic acid with at least 90% identity to SEQ ID NO: 74 (Cas9 nuclease) or SEQ ID NO: 75 (ZmCas9). [0155] 52. The method of embodiment 51, wherein the nucleic acid encoding the Cas9 nuclease is fused to at least one nuclear localization signal (NLS), and the NLS has a polynucleotide sequence selected from SEQ ID NOS: 163-168. [0156] 53. The method of any one of embodiments 38-47 and 50-52, wherein the vector further comprises a second nucleic acid sequence encoding an sgRNA. [0157] 54. The method of embodiment 53, wherein the sgRNA is capable of binding the target sequence, and the target sequence is selected from the group consisting of SEQ ID NO: 91 (GWDela), SEQ ID NO: 92 (GWDe24b), SEQ ID NO: 93 (GWDe24c), and SEQ ID NO: 94 (GWDe25a). [0158] 55. The method of any one or more of embodiments 53-54, wherein the second nucleic acid comprises a sequence with at least 90% identity to SEQ ID NOS: 95 (ZmU3P1:sgRNA_GWDe24b), SEQ ID NO: 96 (ZmU3P2: sgRNA_GWDe24b), SEQ ID NO: 97 (ZmU3.8P:sgRNA_GWDe24b), SEQ ID NO: 98 (ZmU3P2:sgRNA_GWDe24c), SEQ ID NO: 99 (ZmU3P2:sgRNA_GWDe25a) and SEQ ID NO: 100 (ZmU3P2:sgRNA_GWDe1a). [0159] 56. The method of any one or more of embodiments 38-55, wherein the vector further comprises a nucleic acid promoter operably linked to the first nucleic acid or the second nucleic acid. [0160] 57. The method of embodiment 56, wherein the nucleic acid promoter comprises a sequence with at least 90% identity to a reference sequence selected from the group consisting of: SEQ ID NO: 78 (MzU3.8), SEQ ID NO: 79 (ZmU3), SEQ ID NO: 82 (ZmU3P1), SEQ ID NO: 84 (ZmU3P2) and SEQ ID NO: 86 (MzU3.8). [0161] 58. A genetically engineered plant produced by the method of any one of one of embodiments 38-57, or a progeny or descendant thereof, wherein the plant, progeny or descendant thereof comprises the alteration. [0162] 59. The genetically engineered plant of embodiment 58 having an elevated level of starch in comparison to a plant of the same genetic background comprising wild type Glucan Water Dikinase. [0163] 60. A method of increasing a starch level in a plant comprising expressing a nucleic acid in the plant that encodes a nuclease capable of inducing a double-strand break at a target sequence and selecting a homozygous plant that includes an alteration in the target sequence and has an elevated level of starch, wherein the target sequence is included in an endogenous gene encoding a Glucan Water Dikinase only. [0164] 61. A method of agricultural processing comprising:

[0165] expressing in a plant a nucleic acid encoding a nuclease capable of inducing a double-strand break at a target sequence, wherein the target sequence is included in an endogenous gene encoding a Glucan Water Dikinase;

[0166] selecting a homozygous plant that includes an alteration in the target sequence and has an elevated level of starch; and

[0167] processing the homozygous plant, wherein the processing comprises one or more procedures selected from harvesting, bailing, shredding, drying, fermenting, hydrolyzing with chemicals, hydrolyzing with exogenous enzymes and combining with plant biomass. The method may also comprise the method for producing a genetically engineered plant of any one or more of embodiments 63-71. [0168] 62. A method of preparing animal feed comprising: expressing in a plant a nucleic acid encoding a nuclease capable of inducing a double-strand break at the target sequence, wherein the target sequence is included in an endogenous gene encoding a Glucan Water Dikinase;

[0169] selecting a homozygous plant that includes an alteration in the target sequence and has an elevated level of starch; and

[0170] performing at least one procedure selected from the group consisting of: harvesting, bailing, shredding, drying, ensiling, pelletizing, combining with a source of edible fiber, and combining with plant biomass. The method may also comprise the method for producing a genetically engineered plant of any one or more of embodiments 63-71. [0171] 63. A method for producing a genetically engineered plant comprising an engineered nucleic acid that encodes an altered Glucan Water Dikinase comprising modifying a sequence of an endogenous nucleic acid of at least one allele of a gene that encodes a Glucan Water Dikinase in a plant, wherein the modified engineered nucleic acid is an engineered nucleic acid and the modified plant is the genetically engineered plant. [0172] 64. The method of embodiment 63, wherein the genetically engineered plant is homozygous for the gene that includes the mutation and all alleles include the sequence of the engineered nucleic acid. [0173] 65. The method of embodiment 63, wherein the genetically engineered plant is heterozygous for the gene that includes the mutation. [0174] 66. The method of any one or more of embodiments 63 or 65 further comprising self-crossing the genetically engineered plant and obtaining progeny. [0175] 67. The method of any one or more of embodiments 63-65 further comprising crossing the genetically engineered plant and a non-genetically engineered plant of the same genetic background and obtaining progeny. [0176] 68. The method of any one or more of embodiments 66-67 comprising analyzing the progeny for the presence of the altered Glucan Water Dikinase and selecting a progeny plant that includes the mutation. [0177] 69. The method of embodiment 63 comprising the genetically engineered plant of any one or more of embodiments 18-34 and 58-59. [0178] 70. The method of embodiment 63, wherein the step of modifying is performed by a method of any one of embodiments 35-36. [0179] 71. The method of embodiment 63, wherein the step of modifying is performed by using a genetic construct of any one of embodiments 2-16. [0180] 72. A kit for identifying a modified sequence of an endogenous gene encoding Glucan Water Dikinase in a sample, wherein the kit comprises a first primer and a second primer, wherein the first primer and the second primer are capable of amplifying a target sequence in the endogenous gene encoding Glucan Water Dikinase and the target sequence comprises a nucleic acid sequence with at least 90% identity to a reference sequence selected from SEQ ID NOS: 1-4, 75, 171-187, 189 and 192. [0181] 73. The kit of embodiment 72 urther comprising one or more component for detecting at a modification in the amplified region of the target sequence. [0182] 74. The kit of any one or more of embodiments 72-73 wherein, the first primer comprises a nucleic acid sequence selected from SEQ ID NOS: 6, 7, 9, 11, 101, 103, 105, 110, and 111. [0183] 75. The kit of any one or more of embodiments 72-74, wherein the second primer comprises a nucleic acid sequence selected from SEQ ID NOS: 5, 8, 10, 102, and 104. [0184] 76. The kit of any one or more of embodiments 72-75, wherein the first primer and the second primer are capable of amplifying the target sequence to produce an amplified product comprising a modified target sequence. [0185] 77. The kit of any one or more of embodiments 73-76, wherein the amplified target sequence comprises a sequence selected from SEQ ID NOS: 12-40, 106-107, 114-120, 131-146, and 188. [0186] 78. The kit of any one or more of embodiments 72-76, wherein the modified target sequence is capable of hybridizing to the sequence of the nucleic acid comprising a sequence selected from SEQ ID NOS: 12-40, 106-107, 114-120, 131-146, and 188 under conditions of high stringency. [0187] 79. The kit of any one or more of embodiments 72-78, wherein the sample comprises plant matter derived from a genetically engineered plant having at least one mutation in an endogenous gene encoding the Glucan Water Dikinase. [0188] 80. A method of identifying a modified sequence of an endogenous gene encoding Glucan Water Dikinase in a sample comprising:

[0189] contacting a sample with a first primer and a second primer;

[0190] amplifying a target sequence included in the endogenous gene encoding Glucan Water Dikinase and the target sequence comprises a nucleic acid sequence with at least 90% identity to a reference sequence selected from SEQ ID NOS: 1-4, 75, 171-187, 189 and 192; and

[0191] detecting a modification in the target sequence. [0192] 81. The method of embodiment 79, wherein the modification in the target sequence comprises a sequence selected from SEQ ID NOS: 12-40, 106-107, 114-120, 131-146, and 188. The method of identifying may be added to any one or more of embodiments 60-71. [0193] 82. A method of preparing animal feed comprising processing a genetically engineered plant comprising a nucleic acid encoding a restricting enzyme capable of cutting a target sequence, wherein the target sequence is in an endogenous gene encoding a Glucan Water Dikinase, wherein upon the expression of the nucleic acid, the genetically engineered plant has an altered level of vegetative starch compared to the level of vegetative starch in a non-genetically engineered plant, and processing includes at least one of operation selected from the group consisting of harvesting, bailing, grinding, milling, chopping, size reducing, crushing, extracting a component from the feedstock, purifying a component or portion of the feedstock, and extracting or purifying starch. [0194] 83. The method of embodiment 82, wherein the restricting enzyme is selected from the group consisting of a meganuclease, a zinc-finger nuclease, and a TAL effector nuclease. [0195] 84. The method of embodiment 83, wherein the meganuaclease is selected from the group consisting of I-CreI, I-Dmol, I-SceI, E-Dmel, and DmoCre.

[0196] Further embodiments herein may be formed by supplementing an embodiment with one or more element from any one or more other embodiment herein, and/or substituting one or more element from one embodiment with one or more element from one or more other embodiment herein.

EXAMPLES

[0197] The following non-limiting examples are provided to illustrate particular embodiments. The embodiments throughout may be supplemented with one or more detail from one or more example below, and/or one or more element from an embodiment may be substituted with one or more detail from one or more example below.

Example 1

Meganuclease-Based Modification of GWD Gene in Maize and Sorghum Genomes

[0198] Meganuclease constructs were designed that target GWD exon 24, which is near the predicted encoded active site of the enzyme, with the intent of introducing a mutation that inactivates GWD (null mutation). Meganuclease-induced GWD DNA mutants were identified and characterized in maize and sorghum.

[0199] In order to engineer I-CreI homing endonucleases with specificities against GWD genes in maize and sorghum genomes, two nucleotide sequences were selected from the previously annotated full length GWD genes of maize and sorghum. The sequence selection was based on the existence of the high nucleotide sequence identity between maize and sorghum sequences (95% nucleotide sequence identity) and the presence of a sequence motif in exons #24 of both crops that is required for GWD protein activity. The goal was to develop two meganuclease constructs in such a way that each of them would be specific for GWD modification in both maize and sorghum. Targeted genome modifications at the selected GWD sequences using the meganuclease approach would lead to expression of GWD protein variants lacking the active site (truncated proteins or modified proteins expressed from the frame shift containing coding sequences) and therefore being catalytically inactive. The selected sequences of ZmGWD (maize) and SbGWD (sorghum) shown below were supplied to Precision Biosciences, Inc. for designing meganucleases GWD9-10272 and GWD7-8. 226.

[0200] The target sequence for the meganuclease GWD-9/10. 272 (pAG4715) is: ATCCTTGTGGCAAAGAGTGTCA (SEQ ID NO: 41).

[0201] The target sequence for the meganuclease GWD-7/8.226 target sequence (pAG4716) is: GTAGTTGGTGTAATTACACCTG (SEQ ID NO: 42).

[0202] The DNA sequences within exon 24 that are recognized by the designed meganucleases are underlined. The sequences in the uppercase letters show exon 24, while the sequences in lowercase letters represent flanking introns. The CAT codon that is double-underlined encodes a Histidine residue that is critical for GWD protein activity.

TABLE-US-00001 >ZmGWD_Exon24 (SEQIDNO:3) aagtgatactagtgaccctctccacaattttatgcgaaccacagaaatta ataatatattctattactctgcacctgacatctggctcctgctatcagTT GGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGAT GAGTTACTTGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGT GGCAAAGAGTGTCAAGGGAGAGGAAGAAATACCAGATGGAGTAGTTGGTG TAATTACACCTGATATGCCAGATGTTCTGTCTCATGTGTCAGTCCGAGCA AGGAATAGCAAGgtttatcttcacagctatgttgcaagatttcttgaatt ttttctcttgtattgatgttgacatactagctttttcctaat >SbGWD_Exon24 (SEQIDNO:4) aagtggtactagtgacctctccacagttttatgtgaaccacagaaattaa atatgataatatattctattactctgcacctgacatctggctcctgataa cagTTGGCAGGTTATAAGCCCAGTTGAAGTATCAGGTTATGTGGTTGTGG TTGATGAGTTACTTGCTGTCCAGAACAAATCTTATGATAAACCAACCATC CTTGTGGCAAAGAGTGTCAAGGGAGAGGAAGAAATACCAGATGGAGTAGT TGGTGTAATTACACCTGATATGCCAGATGTTCTGTCCCATGTGTCAGTCC GAGCAAGGAATAGCAAGgtttattttcacagttatgttgcaagctttctc agattttttttcttgtatcgatgttgacataccagttttttcctaat

[0203] Clustal software was used to align selected ZmGWD and SbGWD sequences. (Larkin MA et al., 2007; Goujon M et al., 2010, both of which are incorporated herein by reference as if fully set forth).

[0204] CLUSTAL 2.1 multiple sequence alignment

TABLE-US-00002 SbGWD_Exon24 aagtggtactagtgacctctccacagttttatgtgaaccacagaaattaaatatgataa 59 ZmGWD_Exon24 aagtgatactagtgaccctctccacaattttatgcgaaccacagaaatta------ataa 54 ************************************************** SbGWD_Exon24 tatattctattactctgcacctgacatctggctcctgataacagTTGGCAGGTTATAAGC 119 ZmGWD_Exon24 tatattctattactctgcacctgacatctggctcctgctatcagTTGGCAGGTTATAAGC 114 ********************************************************** SbGWD_Exon24 CCAGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACTTGCTGTCCAGAACAAA 179 ZmGWD_Exon24 CCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACTTGCTGTCCAGAACAAA 174 *********************************************************** SbGWD_Exon24 TCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGGAGAGGAAGAAATACCA 239 ZmGWD_Exon24 TCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGGAGAGGAAGAAATACA 234 ************************************************************ SbGWD_Exon24 GATGGAGTAGTTGGTGTAATTACACCTGATATGCCAGATGTTCTGTCCCATGTGTCAGTC 299 ZmGWD_Exon24 GATGGAGTAGTTGGTGTAATTACACCTGATATGCCAGATGTTCTGTCTCATGTGTCAGTC 294 *********************************************************** SbGWD_Exon24 CGAGCAAGGAATAGCAAGgtttattttcacagttatgttgcaagctttctcagatttttt 359 ZmGWD_Exon24 CGAGCAAGGAATAGCAAGgtttatcttcacagctatgttgcaagatttcttgaatttttt 354 ****************************************************** SbGWD_Exon24 ttcttgtatcgatgttgacataccagttttttcctaat 397(SEQIDNO:4) ZmGWD_Exon24 ctcttgtattgatgttgacatactagctttttcctaat 392(SEQIDNO:3) ***********************************

[0205] Development of plant transformation vectors for expressing meganucleases:

[0206] The meganuclease sequences GWD-9/10.272[SEQ ID NO: 1089 and GWD-7/8.226 [SEQ ID NO: 109], which were provided by Precision Biosciences, Inc., were further modified by adding BamHI restriction site at 5 and AvrII site at 3' ends using PCR approach. Subsequently, GWD-9/10.272 and GWD-7/8.226 nucleotide sequences were cloned into pAG4500 vector as BamHI-AvrII fragments between the maize ubiquitin 1 gene promoter and Nos transcriptional terminator sequences to generate respectively plant transformation vectors pAG4715 and pAG4716. FIG. 1 and FIG. 2 illustrate respective maps of pAG4715 and pAG4716 vectors. Referring to FIGS. 1 and 2, pAG4715 and 4716 include a maize ubiquitin promoter (ZmUbil), a maize ubiquitin intron (ZmUbil intron), and a polyadenilation signal NosT serving as the transcription terminator. Both vectors also include a phosphomannose isomerase gene (PMI) as a selectable marker, At NLS (nuclear localization sequence), ZmKozak, mUBQmono, T-DNA right and left borders (RB and LB, respectively), a streptothricin acetyltransferase gene, and an aminoglycoside acetyltransferse (aadA) gene conferring resistance to streptomycin. pAG4715 includes a GWD9-10.272 meganuclease sequence [SEQ ID NO: 108] and pAG4716 includes a GWD7-8.226 meganuclease sequence [SEQ ID NO: 109].

[0207] pAG4715 and pAG4716 were used to generate transgenic events and mutants in maize and sorghum.

[0208] Sequences of the target proteins, genes, mutants and vectors used herein are listed in Table 1.

TABLE-US-00003 TABLE 1 Description of Sequences SEQ ID NO Description Type 1 ZmGWD coding sequence DNA 2 SbGWD coding sequence DNA 3 ZmGWD Exon 24 (includes introns) DNA 4 SbGWD Exon 24 (includes introns) DNA 182 ZmGWD Exon 24 (no introns) DNA 183 SbGWD Exon 24 (no introns) DNA 184 SbGWD Exon 7 (no introns) DNA 5 Mega-1 (4716) PCR Primer Reverse DNA 6 Mega-1 (4716) PCR Primer Forward DNA 7 Mega-2 (4715) PCR Primer Forward DNA 8 Mega-2 (4715) PCR Primer Reverse DNA 9 ZmGWD mega-2 PCR Primer Forward DNA 10 ZmGWD mega-2 PCR Primer Reverse DNA 11 SbGWD mega-2 PCR Primer Forward DNA 13 SbGWD mega-2 PCR Primer Reverse DNA 12 M16 (Zm GWD Exon 24 - no introns) DNA 13 M17 (Zm GWD Exon 24 - no introns) DNA 14 M18 (Zm GWD Exon 24 - no introns) DNA 15 M27 (Zm GWD Exon 24 - no introns) DNA 16 M1 (Zm GWD Exon 24 - no introns) DNA 17 M11 (Zm GWD Exon 24 - no introns) DNA 18 M10 (Zm GWD Exon 24 - no introns) DNA 19 M3 (Zm GWD Exon 24 - no introns) DNA 20 M8 (Zm GWD Exon 24 - no introns) DNA 21 M14 (Zm GWD Exon 24 - no introns) DNA 22 M13 (Zm GWD Exon 24 - no introns) DNA 23 M12 (Zm GWD Exon 24 - no introns) DNA 24 M22 (Zm GWD Exon 24 - no introns) DNA 25 M23 (Zm GWD Exon 24 - no introns) DNA 26 M24 (Zm GWD Exon 24 - no introns) DNA 27 M20 (Zm GWD Exon 24 - no introns) DNA 28 M21 (Zm GWD Exon 24 - no introns) DNA 29 M4 (Zm GWD Exon 24 - no introns) DNA 30 M19 (Zm GWD Exon 24 - no introns) DNA 31 M26 (Zm GWD Exon 24 - no introns) DNA 32 M25 (Zm GWD Exon 24 - no introns) DNA 33 M15 (Zm GWD Exon 24 - no introns) DNA 34 M5 (Zm GWD Exon 24 - no introns) DNA 35 M2 (Zm GWD Exon 24 - no introns) DNA 36 M28 (Zm GWD Exon 24 - no introns) DNA 37 M6 (Zm GWD Exon 24 - no introns) DNA 38 M9 (Zm GWD Exon 24 - no introns) DNA 39 M7 (Zm GWD Exon 24 - no introns) DNA 40 M29 (Zm GWD Exon 24 - no introns) DNA 106 Mutant Sb4715_1 (Wt + ins) DNA 107 Mutant Sb4715_2 (WT + del) DNA 41 Meganuclease GWD-9/10x.272 target DNA sequence (pAG4715) 42 Meganuclease GWD-7/8x target sequence DNA (pAG4716) 43 ZmGWD (wild type protein) Amino acid 44 SbGWD (wild type protein) Amino acid 45 ZmGWD M1 (mutant GWD protein) Amino acid 46 ZmGWD M2 (mutant GWD protein) Amino acid 47 ZmGWD M3 (mutant GWD protein) Amino acid 48 ZmGWD M4 (mutant GWD protein) Amino acid 49 ZmGWD M5 (mutant GWD protein) Amino acid 50 ZmGWD M6 (mutant GWD protein) Amino acid 51 ZmGWD M7 (mutant GWD protein) Amino acid 52 ZmGWD M8 (mutant GWD protein) Amino acid 53 ZmGWD M9 (mutant GWD protein) Amino acid 54 ZmGWD M10 (mutant GWD protein) Amino acid 55 ZmGWD M11 (mutant GWD protein) Amino acid 56 ZmGWD M12 (mutant GWD protein) Amino acid 57 ZmGWD M13 (mutant GWD protein) Amino acid 58 ZmGWD M14 (mutant GWD protein) Amino acid 59 ZmGWD M15 (mutant GWD protein) Amino acid 60 ZmGWD M16 (mutant GWD protein) Amino acid 61 ZmGWD M17 (mutant GWD protein) Amino acid 62 ZmGWD M18 (mutant GWD protein) Amino acid 63 ZmGWD M19 (mutant GWD protein) Amino acid 64 ZmGWD M20 (mutant GWD protein) Amino acid 65 ZmGWD M21 (mutant GWD protein) Amino acid 66 ZmGWD M22 (mutant GWD protein) Amino acid 67 ZmGWD M23 (mutant GWD protein) Amino acid 68 ZmGWD M24 (mutant GWD protein) Amino acid 69 ZmGWD M25 (mutant GWD protein) Amino acid 70 ZmGWD M26 (mutant GWD protein) Amino acid 71 ZmGWD M27 (mutant GWD protein) Amino acid 72 ZmGWD M28 (mutant GWD protein) Amino acid 73 ZmGWD M29 (mutant GWD protein) Amino acid 74 Mutant protein Sb4715_1 (WT + ins) Amino acid 75 Mutant protein Sb4715_2 (WT + del) Amino acid

Example 2

Application of TALENs for Targeted Modification of GWD Gene in Sorghum Genome

[0209] Two pairs of DNA sequences were selected in each of the exons 7 and 24 of the sorghum GWD gene (SbGWD) for development of four custom TAL DNA-binding domains that will be fused to a truncated FokI nuclease sequence. The sorghum exon 24 was selected because it contains the GWD active site and to compare with other endogenous DNA editing technologies in maize, such as meganuclease and CRISP/Cas9 technologies. The sorghum exon 7 was chosen in the upstream region of the GWD gene sequence for producing shorter truncated versions of the GWD protein. Selection of the sequences for DNA-binding domains was performed on Life Technologies web site using a proprietary program. The two pairs of TAL DNA binding domains fused to truncated Fokl endonuclease for targeted sorghum genome modifications in exons 7 and 24 of the GWD gene are being constructed by Life Technologies. Each pair of TALENs will recognize top and bottom strands of genomic DNA sequence at the respective GWD sites to target FokI nuclease for DNA cleavage.

[0210] SbGWD nucleotide sequences selected for TALENs-based GWD modification. The SbGWD_exon7 sequence is positioned within nt 736-969 the SbGWD coding sequence (SEQ ID NO: 2):

TABLE-US-00004 >SbGWD_exon7 (SEQIDNO:184) GAGGAGTATGAAGCTGCACGAGCTGAGTTAATAGAGGAATTAAATAGAG GTGTTTCTTTAGAGAAGCTTCGAGCTAAATTGACAAAAACACCTGAAGCA CCTGAGTCAGATGAACGTAAATCTCCTGCATCTCGAATGCCCGTTGATAA ACTTCCAGAGGACCTTGTACAGGTGCAGGCTTATATAAGGTGGGAGAAAG CGGGCAAGCCAAATTATCCTCCTGAGAAGCAACTG

[0211] The SbGWD_exon24 sequence is positioned within nt 3030-3243 the SbGWD coding sequence (SEQ ID NO: 2):

TABLE-US-00005 >SbGWD_exon24 (SEQIDNO:183) TTGGCAGGTTATAAGCCCAGTTGAAGTATCAGGTTATGTGGTTGTGGTTG ATGAGTTACTTGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTG TGGCAAAGAGTGTCAAGGGAGAGGAAGAAATACCAGATGGAGTAGTTGG TGTAATTACACCTGATATGCCAGATGTTCTGTCCCATGTGTCAGTCCGAG CAAGGAATAGCAAG

[0212] Underlined sequences in each exon represent selected TAL DNA binding sites with the left sequence being specific for the upper DNA strand and the right sequence targeting the bottom DNA strand. A codon encoding catalytically important Histidine residue for GWD protein activity is double-underlined and in bold within exon 24. The TALENs specific for exon 7 or exon 24 will be cloned as respective pairs into pAG4500-based plant transformation vector.

Example 3

Plant Transformation and Analysis

[0213] Maize and Sorghum Transformation: DNA from Agrobacterium was extracted using the protocol described in the Plasmid pSB1 operating manual. Plant DNA was extracted using Qiagen DNeasy Plant Mini kit (69140). Maize and sorghum embryos were transformed with GWD meganuclease targeting constructs pAG4715 and/or pAG4716 according to Negrotto D et al. 2000 Plant Cell Rep 19: 798; Ishida Y et al. 1996 Nat Biotech 14: 74, which is incorporated herein by reference as if fully set forth. Briefly, embryogenic callus from wild-type AxB maize was inoculated with LBA4404 Agrobacterium cells harboring the appropriate transformation plasmid. Agrobacterium-mediated transformation of immature maize embryos was performed as described on Negrotto D et al. The expression cassettes for GWD meganucleases were cloned into the Kpnl-EcoRI sites of an intermediate vector capable of recombining with the pSB1 vector in triparental mating in Agrobacterium tumefaciens strain LBA4404 using procedures reported previously (Ishida Y et al. 1996 Nat Biotech 14: 745; Hiei Y et al. 1994 Plant J 6: 271; Hiei Y and Komari T 2006 Plant Cell Tissue Organ Cult. 85:27; Komari T et al. 1996 Plant J 10:165). Maize (Zea mays cultivars HiII, A188 or B73) stock plants were grown in a greenhouse under 16 hours of daylight at 28 C. Immature zygotic embryos were isolated from the kernels and inoculated with the Agrobacterium solution containing the genes of interest. After inoculation immature embryos were grown in a tissue culture process for 10-12 weeks. Well-developed seedlings with leaves and roots were sampled for PCR analysis to identify transgenic plants containing the genes of interest. PCR positive and rooted plants were rinsed with water to wash off the agar medium, and transplanted to soil and grown in the greenhouse to generate seeds and stover.

[0214] Sorghum transformation was carried according to the protocol of Gao et al., 2005. Regeneration of the transgenic plants was performed according to Elkonin and Pakhomova, 2000.

[0215] DNA from Agrobacterium was extracted using the protocol described in the Plasmid pSB1 operating manual. Plant DNA was extracted using Qiagen DNeasy Plant Mini kit (69140).

[0216] 10TE+SarkosylPlant DNA Isolation for 96 well plates: Briefly, a COSTAR grinding block was filled with leaf samples, one 5 mm steel bead was added to each well with a sample and the storage mat block was applied using a storage mat applicator to seal the block. Samples were stored at 80 C. for at least 30 min before grinding or until processing time. For processing, samples were ground for 45 sec using the Klecko Pulverizer & Secure grinder at maximum speed. Sealing was removed and discarded. Three hundred microliters of 10TE+Sarkosyl buffer (5 mL 1M Tris, 1 mL 0.5M EDTA, 0.5 g sarkosyl, 46 mL ddH.sub.2O) was added to each sample using a multichannel pipette and a sterile solution basin. The plate was incubated on a shaker for 10 min at 300 rpm, and spun for 3 min at 4000 rpm. Supernatant was removed and discarded, and the pellets were resuspended in 1TE buffer. One hundred fifty microliter sample aliquots were added to the 96 well PCT plate. The PCR plate was sealed with aluminum foil. For best results, DNA isolation and PCR were performed on the same date.

[0217] Transgenic Diagnostic PCR Reaction Setup: The complete PCR reaction mix was as follows: 15 l 2 GoTaq MM (GoTaq Green Master Mix (PROMEGA #M712), 3 l of combined forward and reverse primers specific to the gene of interest (each mixed at 10 M), 2 l DNA prep, and water to adjust volume to 30 l. Twenty eight microliters of the complete PCR reaction mix per well were aliquoted into a PCR plate (FISHER, #14230236). Two microliters plant DNA sample were aliquoted into each well of the PCR plate. Positive control and no template negative control were used in each PCR reaction. Control Agrobacterium DNA was diluted 1:100 in TE buffer to yield clear bands. The PCR plate was sealed with a sealing mat (COSTAR #6555) and roller. PCR was performed at BIORAD PTC-100 thermocycler. The thermocycler programs were as follows: 1) 95 C-3 min; 30 cycles 95 C.-30 sec, 5 C.-30 sec, 72 C.- 45 sec; 72 C.-5 min; 10 C. (hold), and 2) 90 C. for 30 min and 10 C. (hold). Twelve microliters of each PCR reaction was loaded onto Ready Agarose 96 Plus gel 3% (BIORAD #161-3062) and ran at approximately 100V for 20 minutes before viewing with a BIORAD gel doc system equipped with Quantity One software. Quick-Load 50bp DNA Ladder (NEB N04735) was used to identify the size of the PCR fragments. 10 TBE Buffer (Promega V4251) was used.

[0218] In line monitor of starch content in living corn leaf using Fourier Transform Near-infrared (FT-NIR) Technique: The starch content in corn leaf tissue is an important factor for animal feed and biofuel production. The commonly used GOPOD assay is not applicable for real-time monitoring in living tissue because the assay is invasive, requiring physical tissue samples, and labor intensive. Predictive models of starch content based on the FT-NIR spectra of dry blends of native and maize leaf starches or corn flour (wet and dry) were developed using partial least squares regression. Three key factors determine a successful application of FT-NIR techniques for fast chemical characterization: accurate and repeatable NIR spectral acquisition, reliable calibration data, and robust chemometric analysis. For analysis, the following materials were used: a spectrophotometer (Perkin Elmer Spectrum One NTS Waltham, Mass.), Unscrambler (Version 10.2., Camo Software Inc., Woodbridge, N.J.), an oven, Hi-maize resistant starch (Honeyville, Brigham City, Utah), and Starch (Product No. S516-500, Fisher Scientific). All blank and test samples were diluted 10 using deionized water and the unreacted starch content was determined using a glucose oxidase-peroxidase (GOPOD) colorimetric assay (Megazyme International, Wicklow, Ireland).

[0219] Sample preparation: A total of 56 dry starch blend samples with 0-33% starch content were prepared by mixing weight proportions of HI-MAIZE resistant starch (Honeyville, Brigham City, Utah. ) with starch (Product No. S516-500, Fisher Scientific). The Honeyville product contains HI-MAIZE 260 (Ingredion, Bridgewater, N.J.) resistant starch that has been isolated from high amylose corn hybrids produced through traditional plant breeding, and contains 33% digestible, or glycemic starch.

[0220] One hundred fifty green leaf samples from different living maize plants at certain age or with different starch accumulation were collected. One hundred samples were oven-dried and 50 samples were left undried (wet). Leaf samples were ground to 0.5 mm and stored in plastic sample bags for moisture equilibration. Moisture content was measured using standard methods.

[0221] Starch determination: The starch content was analyzed for starch blends, wet and dry green tissue or corn flour sample using GOPOD assay.

[0222] Scanning, processing and analyses of FT-NIR spectra: Scanning-Approximately a 5 g milled sample was poured in a smaller NIRA cup, leveled, and scanned 16 times with a manual rotation between each scan. This procedure was repeated five times with separate subsamples and the resulting spectral scans were averaged. A total of 56 samples of starch blends were used to create starch models. 36 samples were used in the calibration set, 14 samples were used in the validation set, and six samples were used in the test set. The dry ground green tissue or flour models were made using 100 samples of corn leaf or seeds. For calibration, validation, and testing, 72, 20, and 8 samples were used, respectively. The wet ground corn models were made using 49 samples of corn leaf or corn seeds. 36 samples were used for calibration, 10 samples were used for validation, and three samples were used for the test set.

[0223] Processing and analyses of FT-NIR spectra-Unscrambler (Version 10.2., Camo Software Inc., Woodbridge, N.J.) was used to process and analyze the spectral data, build and validate the calibration, and test the regression models. Multiplicative scatter correction (MSC) and a 2.sup.nd derivative-based smoothing technique, such as the Savitzky-Golay (SG) technique, were used for data pretreatment. Partial least squares models using a combination of MSC with SG second derivate pretreated spectral data were developed for starch blends and milled green tissue or ground corn. Examples of measured and predicted (MSC+2.sup.nd Derivative Model) starch content of calibration, validation, and test samples are shown in Table 2.

TABLE-US-00006 TABLE 2 Measured and Predicted (MSC + 2.sup.nd Derivative Model) Starch Content of Calibration, Validation, and Test Samples Starch blends Dry corn flour Wet corn flour Starch Measured Predicted Measured Predicted Measured Predicted content (%) (%) (%) (%) (%) (%) Calibration 2.50 2.52 5.0 6.5 5.0 5.2 5.00 4.89 7.5 7.4 10.0 7.9 10.0 10.1 10.0 10.2 12.5 12.0 15.0 15.6 15.0 14.5 13.2 13.5 20.0 20.0 Validation 4.75 4.7 7.5 7.6 7.5 7.5 10.0 9.8 12.5 12.4 10.0 10.0 15.7 16.0 17.5 17.5 12.0 12.5 18.9 18.9 Test 6.5 6.55 5.0 6.5 7.2 7.3 12.5 12.45 11.5 12.5 11.2 11.5 17.5 18.2 14.5 13.2 12.2 13.5 R.sup.2: Starch blends: Calibration: 0.98, Validation: 0.97, Prediction: 0.97 Dry corn flour: Calibration: 0.86, Validation: 0.80, Prediction: 0.80 Wet corn flour: Calibration: 0.94, Validation: 0.80, Prediction: 0.75

Example 4

Identification and Characterization of Meganuclease-Induced DNA Mutations in the Zea mays and Sorghum Bicolor GWD Genes

[0224] Identification of Gene of Interest (GOI) Positive Maize and Sorghum Transformants: Leaves from maize and sorghum plants transformed with pAG4715 or pAG4716 were sampled, DNA was extracted, and screened for the presence of the meganuclease transgenes included in pAG4715 or pAG4716.

[0225] Screening of Maize and Sorghum Transformants: Plants carrying pAG4715 or pAG4716 transgenes referred to as 4715 or 4716 plants, respectively, were screened for GWD mutations using sequence analysis of PCR-amplified GWD DNA sequences.

[0226] PCR Amplification of GWD: DNA sequences surrounding the meganuclease targeting region on exon 24 were amplified using the ZmGWDmega-2 and SbGWDmega-2 primers shown in Table 3.

TABLE-US-00007 TABLE3 PrimersforGenotyping4715and4716Plants Forward Primer Primer or Product Set Name Reverse Sequence size(bp) Mega-1 Mega-1R Reverse TGATCTTCAGCACGAG 265 (4716) GTTG(SEQIDNO:5) Mega-1 Mega-1F Forward GGCTCCATCTATGCCTG 265 (4716) TATC(SEQIDNO:6) Mega-2 Mega-2F Forward GAGCTCAGTTTCGCTGT 209 (4715) CTATC(SEQIDNO:7) Mega-2 Mega-2R Reverse ATGATCTTCAGCACGA 209 (4715) GGTTG(SEQIDNO:8) ZmGWD ZmGWD Forward GGTTATAAGCCCGGTT 204 mega-2 mega-2F GAAGTA(SEQIDNO:9) ZmGWD ZmGWD Reverse CTATTCCTTGCTCGGAC 204 mega-2 mega-2R TGAC(SEQIDNO:10) SbGWD SbGWD Forward GGCAGGTTATAAGCCC 208 mega-2 mega-2f AGTT(SEQIDNO:11) ZmGWD SbGWD Reverse CTATTCCTTGCTCGGAC 208 mega-2 mega-2r TGAC(SEQIDNO:10)

[0227] Primer sets were diluted to a final concentration of 5 M in nuclease-free water. PCR reaction was performed as described above.

[0228] PCR samples were run on an Eppendorf Mastercycler proS (Eppendorf) using our PMI55 program (95 C., 2 min; 30 cycles [950 C., 30 sec; 55 C., 30 sec; 72 C., 45 sec]; 720 C., 8 min)

[0229] PCR samples were separated on Bio-Rad ReadyAgarose 96 Plus Gels, TBE (#161-3062) and visualized with a Bio-Rad gel imaging system.

[0230] FIG. 3 illustrates an example of a gel showing bands of 4715 and 4716 events or successful incorporation of transgenes from pAG4715 or pAG4716, respectively. Referring to this figure, shifted GWD bands indicate potential insertions and deletions (indels) at the GWD meganuclease targeting site and are marked by asterisks.

[0231] DNA Sequence Characterization of the GWD Indel Alleles:

[0232] Sequencing of Initial GWD PCR Products- PCR products were sequenced at Beckman Coulter Genomics (36 Cherry Hill Dr, Danvers, Mass. 01923) using the same primers used for amplification (ZmGWDmega-2 or SbGWDmega-2). Sequencing allowed differentiation between three different genetic outcomes for the GWD locus, wild type, homozygous mutant, and heterozygous mutant. Wild type had no mutation within the 204 or 208 bp GWD PCR fragment, homozygous carried an indel mutation, and heterozygous carried an unresolvable sequence region (indicating at least one indel) of the GWD PCR fragment.

[0233] Cloning and Sequencing of Individual GWD Alleles. To initiate cloning, GWD was amplified with PCR using the same primer sets as above (ZmGWDmega-2 or SbGWDmega-2) from DNA derived from heterozygous plants to characterize the individual GWD alleles. PCR amplification was confirmed by running 8 l of PCR product on agarose gels as described above and the remaining 22 l of PCR reaction was purified with a Qiagen PCR Purification Kit (28104; Qiagen, Md., USA) and eluted in 30 l of Elution Buffer (EB).

[0234] Purified PCR products were cloned using a TOPO TA Cloning Kit with One Shot TOP10 Competent E. coli (K4500-01; Life Technologies) according to the protocol. For cloning procedure, 4 l of purified PCR product was used for the ligation, ligations were incubated on ice for at least 10 min, and 50 l of each transformation reaction was plated on LB carbenicillin (50 g/ml) -gal plates.

[0235] Eight E. coli colonies from each reaction were picked using a sterile pipet tip and transferred into 20 l of sterile liquid LB with carbenicillin. GWD was then amplified by PCR using the same primer sets as above (ZmGWDmega-2 or SbGWDmega-2) and 2 l of each diluted E. coli clone culture. PCR products were confirmed and sent for sequencing as described above.

[0236] Table 4 describes ZmGWD meganuclease events zygosity, mutation types and locations. In Table 4, ZmGWD mutations were numbered 1-28. The wild type (WT) plant refers to two GWD wild type alleles. Hemizygous event refers to one GWD mutant allele and one GWD wild type allele. Heterozygous event refers to two different GWD mutant alleles.

[0237] Homozygous event refers to two identical GWD mutant alleles.

TABLE-US-00008 TABLE 4 ZmGWD Meganuclease Event Zygosity and Mutations Mutation Mutation Mutation Type Mutation Type Construct/ Locus Locus Locus # Locus # Event Zygosity # (1) # (1) (2) (2) 4715_5 Hemi M18 1 bp del 4715_6 WT GWD wild type 4715_11 Hemi M17 10 bp del 4715_13 Hemi M16 24 bp del 4715_14 Hemi M17 10 bp del 4715_15 Hemi M18 1 bp del 4715_18 WT GWD wild type 4715_20 Homo or two Hetero mutant alleles 4715_25 Hemi M17 10 bp del 4715_28 Hemi M27 16 bp del 4716_1 Hemi M1 4 bp sub 4716_2 Homo M15 40 bp del 4716_3 Hetero M9 15 bp del M6 1 bp del 4716_4 Hetero M11 17 bp del M12 38 bp del 4716_5 Hetero M7 4 bp del M11 17 bp del 4716_6 Hetero M4 9 bp del M14 25 bp del 4716_7 Hemi M1 4 bp sub 4716_8 Homo M11 17 bp del 4716_9 WT GWD wild type 4716_10 Hetero M11 17 bp del M10 1 bp ins 4716_11 Hetero M11 17 bp del M10 1 bp ins 4716_12 Hetero M3 15 bp del M8 6 bp del 4716_13 Homo M14 25 bp del 4716_14 Homo M13 36 bp del 4716_15 Hetero M11 17 bp del M12 38 bp del 4716_18 Hemi M20 1 bp del 4716_20 WT GWD wild type 4716_22 Hetero M5 211 bp ins M11 17 bp del 4716_23 Homo M15 40 bp del 4716_24 Hetero M2 6 bp del M14 25 bp del 4716_25 Hetero M10 1 bp ins M28 27 bp del 4716_26 Hetero M11 17 bp del M12 38 bp del 4716_27 Hetero M11 17 bp del M10 1 bp ins 4716_151 Hemi M10 1 bp ins 4716_152 Hetero M22 10 bp del M23 8 bp del + 15 bp ins (7 bp ins) 4716_153 WT GWD wild type 4716_154 Hetero M22 10 bp del M23 8 bp del + 15 bp ins (7 bp ins) 4716_155 Homo M4 9 bp del 4716_157 Hemi M24 1 bp del 4716_158 Hemi M20 1 bp del 4716_159 Homo M20 1 bp del 4716_160 Hemi M10 1 bp ins 4716_161 Hetero M4 9 bp del M21 33 bp del (57 bp del + 17 bp ins) 4716_162 Hetero M20 1 bp del M19 4 bp del 4716_163 Hemi M26 211 bp ins 4716_164 Hemi M20 1 bp del 4716_165 Homo M4 9 bp del 4716_166 Homo M4 9 bp del 4716_167 Hetero M13 36 bp del M25 2 bp del 4716_201 Homo M29 2 bp del

[0238] DNA sequences for each clone were compared to wild type (WT) GWD using Vector NTI Advance (Version 11.5; Life Technologies). DNA sequences for wild type ZmGWD and SbGWD and transgenic events were compared and shown in the following files: ZmGWD meganuclease mutant DNA sequence alignments; ZmGWD meganuclease mutant protein sequence alignments; SbGWD meganuclease mutant DNA sequence alignments; SbGWD meganuclease mutant protein sequence alignments.

[0239] As shown below, an alignment of the sequences from three PCR products demonstrates insertions and deletions that distinguish maize mutants M5 and M26 from wild type sequence ZmGWD Exon24.

[0240] CLUSTAL O (1.2.1) multiple sequence alignment for ZmGWD for maize mutants M5 and M26:

TABLE-US-00009 ZmGWDExon24 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M5 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M26 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 ************************************************************ ZmGWDexon24 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGG 120 M5 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGG 120 M26 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGG 120 ************************************************************ ZmGWDexon24 AGAGGAAGAAATACCAGATGGAGTA----------------------------------- 145 M5 AGAGGAAGAAATACCAGATGGAGTAGTTGCAGAATTATTGAATTCTTTCATAATTGAACT 180 M26 AGAGGAAGAAATACCAGATGGAGCAGTGTGCTCGGGTACAGCTTCTTATTTCAATGTCTC 180 ************************ ZmGWDexon24 ------------------------------------------------------------ 145 M5 CTATGATGATGCTTTACTT--GATTGTATTATATTGATGCTCAATCATATATTGATGATT 238 M26 CAGTGGGCGTCTTACCTCTATGTTTGTGTTTTTTT-TTAAGTGCAGAAATAGAGAAAGTT 239 ZmGWDexon24 ------------------------------------------------------------ 145 M5 GTTGGAACTTGCTCTCCGATGCAAGGTGATCCAACGGGGGTGTGTCGCAACGTAAACAGG 298 M26 CTTGCAAATATCTACTCTATGAAAAGGACAGCTATTTGGAAATA------TGTGAACAGA 293 ZmGWDexon24 ------------------------------------------------------------ 145 M5 GTTTTCG-CACGAGATGGCAATAGCTCTGT-T---AACCTAGCCTCTCACGGGCACTGTG 353 M26 ACTATCCCCAGTTGCTGGGAAAAACCAAGAAGAAAGTTCCTTCAAATATCTACTCCATGA 353 ZmGWDexon24 ---GTTGGTGTAATTACACCTGATATGCCAGATGTTCTGTCTCATGTGTCAGTCCGAGCA 202 M5 CGGGGGTATTTAATTACACCTGATATGCCAGATGTTCTGTCTCATGTGTCAGTCCGAGCA 413 M26 CGACAAGTGTCTATTACACCTGATATGCCAGATGTTCTGTCTCATGTGTCAGTCCGAGCA 413 ************************************************ ZmGWDexon24 AGGAATAGCAAG 214(SEQIDNO:182) M5 AGGAATAGCAAG 425(SEQIDNO:34) M26 AGGAATAGCAAG 425(SEQIDNO:31) ************

[0241] The below alignment of the sequences from twenty eight PCR products demonstrates modifications, such as deletions and insertions, that distinguish maize mutants M1-M4, M6-M25 and M27-M29 from the wild type sequence ZmGWDExon24 (nt 3030 3243 of SEQ ID NO: 1 (ZmGWD)):

[0242] CLUSTAL O(1.2.1) multiple sequence alignment for maize mutants M1-M4, M6-M25 and M27-M29:

TABLE-US-00010 ZmGWDexon24 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M1 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M2 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M3 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M4 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M6 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M7 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M8 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M9 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M10 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M11 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M12 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M13 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M14 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M15 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M16 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M17 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M18 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M19 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M20 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M21 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M22 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M23 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M24 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M25 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M27 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M28 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 M29 TTGGCAGGTTATAAGCCCGGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 ************************************************************ ZmGWDexon24 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGG 120 M1 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGG 120 M2 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGG 120 M3 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGG 120 M4 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGG 120 M6 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGG 120 M7 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGG 120 M8 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGG 120 M9 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGG 120 M10 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGG 120 M11 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGG 120 M12 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGG 120 M13 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGG 120 M14 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGG 120 M15 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTAATTACAC 120 M16 TGCTGTCCAGAACAAATCTTATGATAAACCAAGGGAGAGGA------------------- 101 M17 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAGGG---------- 110 M18 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAA-GAGTGTCAAGGG 119 M19 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGG 120 M20 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGG 120 M21 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAAAT 120 M22 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGG 120 M23 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGG 120 M24 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGG 120 M25 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGG 120 M27 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAGGGAGAGAT---- 116 M28 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGG 120 M29 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGAGTGTCAAGGG 120 ******************************** ZmGWDexon24 AGAGGAAGAAATACCAGATGGAGTAGTTGGTGTA-------ATTACACCTGATATGCCAG 173 M1 AGAGGAAGAAATACCAGATGGAGTAGTTGGAAGA-------AATACACCTGATATGCCAG 173 M2 AGAGGAAGAAATACCAGATGGAGTAGTTGTT-------------ACACCTGATATGCCAG 167 M3 AGAGGAAGAAATACCAGATGGAGCACCT----------------------GATATGCCAG 158 M4 AGAGGAAGAAATACCAGATGGAGTAA----------------TTACACCTGATATGCCAG 164 M6 AGAGGAAGAAATACCAGATGGAGTAGTTGGTAA--------ATTACACCTGATATGCCAG 172 M7 AGAGGAAGAAATACCAGATGGAGTAGTTGGT-----------TTACACCTGATATGCCAG 169 M8 AGAGGAAGAAATACCAGATGGAGTAGTTGGT-------------ATGCCAGATATGCCAG 167 M9 AGAGGAAGAAATACCAGATGGAGTAGTTG-----------------------TATGCCAG 158 M10 AGAGGAAGAAATACCAGATGGAGTAGTTGGTGTAA------ATTACACCTGATATGCCAG 174 M11 AGAGGAAGAAATACCAGATGGAGTAGTTGGTGTCAG------------------------ 156 M12 AGAGGAAGAAATACCAGATGGAGTAGTTGGTGTCAGTCCGAGCAAGGAATAGCAAG---- 176 M13 AGAGGAAGAAATACCAGATGTTCTGTCTCATGTGTC------------------------ 156 M14 AGAGGAAGAATTACA--------------------------------CCTGATATGCCAG 148 M15 CTGATATGC------------------------------------------------CAG 132 M16 ------AGAAATACCAGATGGAGTAGTTGGT-------GTAATTACACCTGATATGCCAG 148 M17 AGAGGAAGAAATACCAGATGGAGTAGTTGGTGT-A------ATTACACCTGATATGCCAG 163 M18 AGAGGAAGAAATACCAGATGGAGTAGTTGGTGTA-------ATTACACCTGATATGCCAG 172 M19 AGAGGAAGAAATACCAGATGGAGTAGTTGGTGT--------ATTACACCTGATATGCCAG 172 M20 AGAGGAAGAAATACCAGATGGAGTAGTTGGTGT--------ATTACACCTGATATGCCAG 172 M21 CTTATGATAAACC----------------------------------------ATGCCAG 140 M22 AGAGGAAGAAATACCAGATGGAGTAGTTGGTGTGA-----------------TATGCCAG 163 M23 AGAGGAAGAAATACCAGATGGAGTAGTTGGCAAAGATAAACCTTGCACCTGATATGCCAG 180 M24 AGAGGAAGAAATACCAGATGGAGTAGTTGGTGA--------ATTACACCTGATATGCCAG 172 M25 AGAGGAAGAAATACCAGATGGAGTAGTTGG---TA------ATTACACCTGATATGCCAG 171 M27 ------------ACCAGATGGAGTAGTTGG-------TGTAATTACACCTGATATGCCAG 157 M28 AGAGGAAGAAACACCTGATA----------------------------------TGCCAG 146 M29 AGAGGAAGAAATACCAGATGGAGTAGTTGG---TA------ATTACACCTGATATGCCAG 171 ZmGWDexon24 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 214(SEQIDNO:182) M1 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 214(SEQIDNO:16) M2 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 208(SEQIDNO:35) M3 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 199(SEQIDNO:19) M4 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 205(SEQIDNO:29) M6 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 213(SEQIDNO:37) M7 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 210(SEQIDNO:39) M8 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 208(SEQIDNO:20) M9 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 199(SEQIDNO:38) M10 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 215(SEQIDNO:18) M11 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 197(SEQIDNO:17) M12 ----------------------------------------- 176(SEQIDNO:23) M13 -------------------AGTCCGAGCAAGGAATAGCAAG 178(SEQIDNO:22) M14 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 189(SEQIDNO:21) M15 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 173(SEQIDNO:33) M16 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 189(SEQIDNO:12) M17 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 204(SEQIDNO:13) M18 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 213(SEQIDNO:14) M19 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 213(SEQIDNO:30) M20 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 213(SEQIDNO:27) M21 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 181(SEQIDNO:28) M22 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 204(SEQIDNO:24) M23 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 221(SEQIDNO:25) M24 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 213(SEQIDNO:26) M25 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 212(SEQIDNO:32) M27 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 198(SEQIDNO:15) M28 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 187(SEQIDNO:36) M29 ATGTTCTGTCTCATGTGTCAGTCCGAGCAAGGAATAGCAAG 212(SEQIDNO:40)

[0243] The amino acid sequences of GWD from twenty nine transgenic maize events and a wild type plant were analyzed and showed deletions and insertions in the wild type ZmGW (SEQ ID NO: 185) protein in the positions of amino acids 1040-1120 that distinguish this protein from maize mutants ZmGWD_M1 (SEQ ID NO: 45), ZmGWD_M2 (SEQ ID NO: 46), ZmGWD_M3 (SEQ ID NO: 47), ZmGWD_M4 (SEQ ID NO: 48), ZmGWD_M5 (SEQ ID NO: 49), ZmGWD_M6 (SEQ ID NO: 50), ZmGWD_M7 (SEQ ID NO: 51), ZmGWD_M8 (SEQ ID NO: 52), ZmGWD_M9 (SEQ ID NO: 53), ZmGWD_M10 (SEQ ID NO: 54), ZmGWD_M11 (SEQ ID NO: 55), ZmGWD_M12 (SEQ ID NO: 56), ZmGWD_M13 (SEQ ID NO: 57), ZmGWD_M14 (SEQ ID NO: 58), ZmGWD_M15 (SEQ ID NO: 59), ZmGWD_M16 (SEQ ID NO: 60), ZmGWD_M17 (SEQ ID NO: 61), ZmGWD_M18 (SEQ ID NO: 62), ZmGWD_M19 (SEQ ID NO: 63), ZmGWD M20 (SEQ ID NO: 4), ZmGWD_M21 (SEQ ID NO: 65), ZmGWD_M22 (SEQ ID NO: 66), ZmGWD_M23 (SEQ ID NO: 67), ZmGWD_M24 (SEQ ID NO: 68), ZmGWD_M25 (SEQ ID NO: 69), ZmGWD_M26 (SEQ ID NO: 70), ZmGWD_M27 (SEQ ID NO: 71), ZmGWD_M28 (SEQ ID NO: 72), and ZmGWD_M29 (SEQ ID NO: 73).

[0244] CLUSTAL 0(1.2.1) multiple sequence alignment of ZmGWD (SEQ ID NO: 43) amino acids 1040-1120:

TABLE-US-00011 ZmGWD PTILVAKSVKGEEEIPDGVVGVITPDMPD----------VLS---HV---------SVR- ZmGWD_M1 PTILVAKSVKGEEEIPDGVVGRNTPDMPD----------VLS---HV---------SVR- ZmGWD_M2 PTILVAKSVKGEEEIPDGV--VVTPDMPD----------VLS---HV---------SVR- ZmGWD_M3 PTILVAKSVKGEEEIPDGA-----PDMPD----------VLS---HV---------SVR- ZmGWD_M4 PTILVAKSVKGEEEIPDG---VITPDMPD----------VLS---HV---------SVR- ZmGWD_M5 PTILVAKSVKGEEEIPDGVVAELLNSFIIELYDDALLDCIILMLNHILMIVGTCSPMQGD ZmGWD_M6 PTILVAKSVKGEEEIPDGVVGKLHLICQM----------FCL---MCQSEQGIARYCLRP ZmGWD_M7 PTILVAKSVKGEEEIPDGVVG-LHLICQM----------FCL---MCQSEQGIARYCLRP ZmGWD_M8 PTILVAKSVKGEEEIPDGV--VGMPDMPD----------VLS---HV---------SVR- ZmGWD_M9 PTILVAKSVKGEEEIPDGV-----VGMPD----------VLS---HV---------SVR- ZmGWD_M10 PTILVAKSVKGEEEIPDGVVGVNYT*---------------------------------- ZmGWD_M11 PTILVAKSVKGEEEIPDGVVGVRCSVSCVSPSKE*------------------------- ZmGWD_M12 PTILVAKSVKGEEEIPDGVVGVSPSK-------E*------------------------- ZmGWD_M13 PTILVAKSVKGEEEI------------PD----------VLS---HV---------SVR- ZmGWD_M14 PTILVAKSVKGEEE--------LHLICQM----------FCL---MCQSEQGIARYCLRP ZmGWD_M15 PTILVAKSNYT*------------------------------------------------ ZmGWD_M16 P--------RERKKYQME*----------------------------------------- ZmGWD_M17 PTIL---VARERKKYQME*----------------------------------------- ZmGWD_M18 PTILVARVSRERKKYQME*----------------------------------------- ZmGWD_M19 PTILVAKSVKGEEEIPDGVVG-VHLICQM----------FCL---MCQSEQGIARYCLRP ZmGWD_M20 PTILVAKSVKGEEEIPDGVVGVLHLICQM----------FCL---MCQSEQGIARYCLRP ZmGWD_M21 PTILVAKSVKIL*----------------------------------------------- ZmGWD_M22 PTILVAKSVKGEEEIPDGVVG---VICQM----------FCL---MCQSEQGIARYCLRP ZmGWD_M23 PTILVAKSVKGEEEIPDGVVGKDKPCT*-------------------------------- ZmGWD_M24 PTILVAKSVKGEEEIPDGVVGELHLICQM----------FCL---MCQSEQGIARYCLRP ZmGWD_M25 PTILVAKSVKGEEEIPDGVVGNYT*----------------------------------- ZmGWD_M26 PTILVAKSVKGEEEIPDGAVCSGTASYFNVSS-GRLTSMFVFFFK-CRNRESSCKYLLYE ZmGWD_M27 PTILVA-----RERYQME*----------------------------------------- ZmGWD_M28 PTILVAKSVKGEEE---------TPDMPD----------VLS---HV---------SVR- ZmGWD_M29 PTILVAKSVKGEEEIPDGVVGNYT*----------------------------------- ZmGWD -------ARNSKVLFATCFDHTTLSELEGYDQKLFSFKPTSADITYREITE(SEQIDNO:185) ZmGWD_M1 -------ARNSKVLFATCFDHTTLSELEGYDQKLFSFKPTSADITYREITE(SEQIDNO:45) ZmGWD_M2 -------ARNSKVLFATCFDHTTLSELEGYDQKLFSFKPTSADITYREITE(SEQIDNO:46) ZmGWD_M3 -------ARNSKVLFATCFDHTTLSELEGYDQKLFSFKPTSADITYREITE(SEQIDNO:47) ZmGWD_M4 -------ARNSKVLFATCFDHTTLSELEGYDQKLFSFKPTSADITYREITE(SEQIDNO:48) ZmGWD_M5 ---PTGVCRNVNRVFARDGNSSVNLASHGHCAGVFNYT*------------(SEQIDNO:49) ZmGWD_M6 VL-TTPLYLNLKDMIRNCFPSSLLLQI*-----------------------(SEQIDNO:50) ZmGWD_M7 VL-TTPLYLNLKDMIRNCFPSSLLLQI*-----------------------(SEQIDNO:51) ZmGWD_M8 -------ARNSKVLFATCFDHTTLSELEGYDQKLFSFKPTSADITYREITE(SEQIDNO:52) ZmGWD_M9 -------ARNSKVLFATCFDHTTLSELEGYDQKLFSFKPTSADITYREITE(SEQIDNO:53) ZmGWD_M10 ---------------------------------------------------(SEQIDNO:54) ZmGWD_M11 ---------------------------------------------------(SEQIDNO:55) ZmGWD_M12 ---------------------------------------------------(SEQIDNO:56) ZmGWD_M13 ------ARNSKVLFATCFDHTTLSELEGYDQKLFSFKPTSADITYREITE(SEQIDNO:57) ZmGWD_M14 VL-TTPLYLNLKDMIRNCFPSSLLLQI*(SEQIDNO:58) ZmGWD_M15 ---------------------------------------------------(SEQIDNO:59) ZmGWD_M16 ---------------------------------------------------(SEQIDNO:60) ZmGWD_M17 ---------------------------------------------------(SEQIDNO:61) ZmGWD_M18 ---------------------------------------------------(SEQIDNO:62) ZmGWD_M19 VL-TTPLYLNLKDMIRNCFPSSLLLQI*-----------------------(SEQIDNO:63) ZmGWD_M20 VL-TTPLYLNLKDMIRNCFPSSLLLQI*-----------------------(SEQIDNO:64) ZmGWD_M21 ---------------------------------------------------(SEQIDNO:65) ZmGWD_M22 VL-TTPLYLNLKDMIRNCFPSSLLLQI*-----------------------(SEQIDNO:66) ZmGWD_M23 ---------------------------------------------------(SEQIDNO:67) ZmGWD_M24 VL-TTPLYLNLKDMIRNCFPSSLLLQI*-----------------------(SEQIDNO:68) ZmGWD_M25 ---------------------------------------------------(SEQIDNO:69) ZmGWD_M26 KDSYLEICEQNYPQLLGKTKK--K-----VPSNIYSMTTSV---YYT*---(SEQIDNO:70) ZmGWD_M27 ---------------------------------------------------(SEQIDNO:71) ZmGWD_M28 -------ARNSKVLFATCFDHTTLSELEGYDQKLFSFKPTSADITYREITE(SEQIDNO:72) ZmGWD_M29 ---------------------------------------------------(SEQIDNO:73)

[0245] For Sorghum bicolor, two meganuclease constructs were used to create GWD mutations, 4715 and 4716. First generation (T0) transformed plants could result in homozygous GWD mutants, hemizygous (WT+ mutation) GWD mutants, or heterozygous (2 different mutations; e.g., allele 1+ allele 2) GWD mutants. The following abbreviations were used: del=deletion; ins=insertion; sub=substitution; SbGWD CDS is wild type sequence. For example, the sequence name Sb4715_1 (WT+ins) has the following meaning: Sb4715 is the construct in Sorghum bicolor; 1 is the transgenic event: WT+ins indicates that T0 event 4715_1 was hemizygous for a GWD mutation, carrying a WT GWD allele and an insertion (ins) GWD allele. The same construct was used for transformation of Zea mays (Zm).

[0246] CLUSTAL nucleic acid alignment between Sorghum bicolor (Sb) GWD sequence and Sorghum bicolor GWD mutants Sb475_1 (WT+ins) and Sb4715_2 (WT+del) showed alterations in the sequences of the mutants compared to wild type SbGWD sequence. The SbGWD_exon24 sequence is positioned within nt 3030-3243 the SbGWD coding sequence (SEQ ID NO: 2). The sequence of Sb475_1 (WT+ins) includes a 13 nucleotide insertion in the position 3139-3149 of SbGWD and a nucleotide substitution in the position 3133-3136 of SbGWD.

[0247] As shown below, an alignment of the sequences from the three PCR products demonstrates insertions and deletions that differentiate Sb4715_1 (WT+ins) and Sb4715_2 (WT+del) and SbGWD exon 24 regions.

[0248] CLUSTAL O(1.2.1) multiple sequence alignment:

TABLE-US-00012 SbGWD_Exon24 TTGGCAGGTTATAAGCCCAGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 Sb4715_1(WT+ ins) TTGGCAGGTTATAAGCCCAGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 Sb4715_2(WT+ del) TTGGCAGGTTATAAGCCCAGTTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGTTACT 60 ************************************************************ SbGWD_Exon24 TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGA---------- 110 Sb4715_1(WT+ ins) TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGAGTAGTTGGTGTAGTT 120 Sb4715_2(WT+ del) TGCTGTCCAGAACAAATCTTATGATAAACCAACCATCCTTGTGGCAAAGA---------- 110 ********************************************** SbGWD_Exon24 ---GTGTCAAGGGAGAGGAAGAAATACCAGATGGAGTAGTTGGTGTAATTACACCTGATA 167 Sb4715_1(WT+ ins) GGTGTATCAAGGGAGAGGAAGAAATACCAGATGGAGTAGTTGGTGTAATTACACCTGATA 180 Sb4715_2(WT+ del) ---GTGTCAAGGGAGAGGAAGAAATACCAGATGGAG------------TTACACCTGATA 155 ******************************************** SbGWD_Exon24 TGCCAGATGTTCTGTCCCATGTGTCAGTCCGAGCAAGGAATAGCAAG 214(SEQIDNO:183) Sb4715_1(WT+ ins) TGCCAGATGTTCTGTCCCATGTGTCAGTCCGAGCAAGGAATAGCAAG 227(SEQIDNO:106) Sb4715_2(WT+ del) TGCCAGATGTTCTGTCCCATGTGTCAGTCCGAGCAAGGAATAGCAAG 202(SEQIDNO:107) ***********************************************

[0249] The prediction of the meganuclease mutant protein amino acid sequences were made using the sequence wild type SbGWD (SEQ ID NO: 44).

Example 5

Mutant Plants Accumulate Elevated Levels of Green Tissue Starch

[0250] Starch was assayed in the first generation (T0) transformed maize and sorghum GWD meganuclease plants. Tissues were collected, dried and milled to a fine powder. The starch content was determined by standard methods (Smith AM and Zeeman SC, Quantification of starch in plant tissues (2006) Nat Protocols 1: 11342-1345, which is incorporated herein by reference as if fully set forth). A total starch content was assayed by adapting the protocol from Megazyme International Ireland Ltd. (Megazyme kit and reagents; cat. #K-TSTA). Briefly, 85 C. and 50 C. heat blocks were set up. From 5 to 15 mg of dry milled tissue were placed into the 1.5 ml boil-proof microcentrifuge tubes. One milliliter of 70% ethanol was added to each tube and samples were vortexed and pelleted. Four hundred microliters of solution 1 was added to each sample. Solution 1 included 1 ml of the thermostable -amylase and 29 ml of 100 mM sodium acetate buffer, pH5.0. The samples were re-suspended and vortexed. Samples were incubated for 12 minutes at 85 C. for 12 minutes, and cooled for 5 minutes at room temperature. Three hundred microliters of the GOPOD reagent (Megazyme kit, cat. #K-TST) was preloaded into each well of the flat bottom 96 well assay plate. Ten microliters of samples were added to each well and compared to 1 L, 5 L, 10 L, and 20 L of glucose standard (lmg/ml), which were also added to their respective wells. The plate was incubated at 50 C. for 20 min. Absorbance was assessed at 510 nm. Referring to FIG. 4, elevated starch is shown for mutants 4715_20 (two mutant alleles), 4716_7 (M1), 4716_1 (M1), 4716_18 (M20), 4716_12 (M3/M8), 4716_23 (M15), 4716_28 (not characterized), 4716_3 (M9/M6), 4716_22 (M5/M11), 4716_24 (M2/M14), 24716_25 (M10/M28), 4716_15 (M11/M12), 4716_5 (M7/M11), 4716_6 (M4/M14), 4716_27 (M11/M10), 4716_4 (M11/M12), 4716_26 (M11/M12), 4716_2 (M15), 4716_13 (M14), 4716_13 (M14), 4716_11 M11/M10), 4716_8 (M11), 4716_10 (M11/M10), and 4716_14 (M13) compared to wild type plants WT_195, WT_18 and WT_6. Many of the homozygous and heterozygous events exhibited greater than 20% starch increase by weight in leaves. Based on a weighted average of starch accumulation in different tissues, we estimated total plant starch (not including grain) to be approximately 10% (weight/weight).

[0251] The levels were significantly higher was observed previously in maize using RNA interference technology, despite the low transcript abundance measured in those experiments. This was a surprising result as it was anticipated that RNAi based silencing would be dominant in the plant and have the same effect as a gene deletion or knock-out strategy.

[0252] FIG. 5 illustrates green tissue starch for selected hemizygous, homozygous, and heterozygous events. FIG. 5 shows mutation type and zygosity of transgenic corn events M17 (4715_14), M18 (4715_15), M1 (4716_1), M20 (4716_18), M3/M12 (4716_12), M9 (4716_3), M7/M11 (4716_5), M4/M14 (4716_6), M11/M12 (4716_4), M15 (4716_2), M14 (4716_13), M11 (4716_8), M11/M10 (4716_10) and M13 (4716_14) have elevated levels of starch compared to non-transgenic control WT (4716_9). It was observed that several events (4716_13 (M14), 4715_15 (M11/M12) and 4716_6 (M4/M14) have greater than average biomass.

Example 6

GWD Knock-Out (GWDko) Cobs have Increased Starch Levels

[0253] TO GWDko and wild type (wt) maize mutant lines were selfed, developed to maturity, dried, and cross-sectioned for staining. Cob sections were stained with Lugol's solution (5% KI) for 4 min and destained with H.sub.2O overnight.

[0254] Mutant events 4716_13, 4716_26, 4716_167, 4716_164, 4716_9, and 4716-153 were analyzed for starch content. The results are shown in Table 5.

TABLE-US-00013 TABLE 5 Starch Content in Mutant Lines Green Tissue Stover Construct_Event Zygosity Starch Starch 4716_13 Homo 229.7 38.5 4716_26 Hetero 220.7 35.3 4716_167 Hetero 112.0 31.7 4716_164 Hemi 30.5 4.0 4716_9 WT 18.8 8.4 4716_153 WT 5.7 1.2

[0255] Referring to Table 5 and FIG. 6, it was shown that homozygous (4716_13) and heterozygous (4716_26 and 4716_167) cobs had increased starch staining compared with hemizygous (4716_164) and wild type (4716_9 and 4716_153) cobs.

Example 7

Construction of CRISPR/Cas Maize Transformation Vectors

[0256] For constructing Cas9 expression cassette, the S. pyogenes Cas9 protein sequence containing Nand Cterminal At nuclear localization sequences (NLS) as well the 3FLAG sequence positioned immediately after the first ATG codon (Jiang et al., 2013) (SEQ ID NO: 74) was chosen for expression in maize. The sequence of S. pyogenes Cas9 containing two SV40 nuclear localization sequences (shown in bold letters) and 3FLAG sequence at Nterminal part (underlined sequence) for expression in maize is as follows:

TABLE-US-00014 (SEQIDNO:74) MDYKDHDGDYKDHDIDYKDDDDKMAPKKKRKVGIHGVPAADKKYSIGLDI GTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEA TRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDK KHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHM IKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAI LSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNEKSNFDLAED AKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTE ITKAPLSASMIKRYDEHHQDLILLKALVRQQLPEKYKEIFFDQSKNGYAG YIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIP HQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSR FAWMTRKSEETITPWNFEEVVDKGASAQSFIERMINFDKNLPNEKVLPKH SLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKINRKVIV KQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEE NEDILEDIVLILTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGR LSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLIFKEDIQKA QVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVI EMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKL YLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLIRSD KNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLIKAERGGLSEL DKAGFIKRQLVETRQIIKHVAQILDSRMNIKYDENDKLIREVKVITLKSK LVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGIALIKKYPKLESEFVYG DYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFEKTEITLANGEIRKRP LIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGESKESIL PKRNSDKLIARKKDWDPKKYGGFDSPIVAYSVLVVAKVEKGKSKKLKSVK ELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRK RMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQ HKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIH LFTLINLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRID LSQLGGDRPKKKRKVGG

[0257] The sequence was back translated and maize codon optimized to produce ZmCas9 (SEQ ID NO: 75). The optimized ZmCas9 nucleotide sequence was synthesized by Genscript. The ZmCas9 was cloned as BamHI-AvrII fragment between maize ubiquitin 1 promoter (ZmUbi1P) and nopaline synthase transcriptional terminator (NosT) sequences into pAG4500 to produce pAG4800.

[0258] The work on construction of sgRNA cassettes involved: 1) identification and isolation of a maize RNA Polymerase III promoter to drive expression of sgRNA; 2) design and synthesis of sgRNA scaffold; and 3) selection of a target gene and 20 bp specific sequences within this gene for guiding Cas9 endonuclease to its target sites.

[0259] The first description of a maize sequence encoding U3 small nuclear RNA (U3snRNA) was reported by Leader et al. in 1994, who isolated MzU3.8 gene (Genebank Accession No. Z29641) (SEQ ID NO: 76) from a maize genomic DNA library and demonstrated that the MzU3.8 U3snRNA is expressed in maize protoplasts. Using BLASTN algorithm and Z29641 sequence to search the Maize Genetics and Genomics Database (http://www.maizegdb.org/) we identified a homologous sequence of maize U3 that was labeled as ZmU3 (SEQ ID NO: 77).

[0260] The ZmU3 is localized on the maize chromosome 8 and is contained within a sequence with nucleotide coordinates 163620300-163621800. The CLUSTAL 2.1 multiple nucleotide sequence alignment of putative promoter regions of MzU3.8 (SEQ ID NO: 78) and ZmU3 (SEQ ID NO: 79) demonstrated 93.8% identity between the two sequences. CLUSTAL 2.1 multiple sequence alignment:

TABLE-US-00015 MzU3.8 GAATTCCATCTAAGTATCTTGGTAAAGCATGGATTAATTTGGATGCTCACTTCAGGTCTA 60 ZmU3 GAATTCCATCTAAGTATGTTGGTAAAGCATGGATTAATTTGGATGCCCACTTCAGGTCTA 60 ********************************************************** MzU3.8 TGCAGCTCCGGTGCCTTGTGATTGTGAGTTGTGACCGATGCTCATGCTATTTTGCATTTC 120 ZmU3 TGCAGCTCCGGTGCCTTGTGATTGTGAGTTGTGACCGATGCTCATGCTATTCTGCATTTC 120 *********************************************************** MzU3.8 TGCGATGTATGATGCTAGTAGATCTTCAAAACTAACAGCGCATGCCATCATCATCCACTG 180 ZmU3 TGCGATGTATGTAGCTAGTAGATCTTCAAAACTAACACCGCATGCCATCATCATCCACTG 180 ********************************************************* MzU3.8 CTTGATTTTAGTCTCACCGCTGGCCAAAAATGTGATGATGCCAGAAACCTCAACTACCTT 240 ZmU3 CTTGATTTTAGTCTCACCGCTGGCCAAAAATGTGATGATGCCAGAAACCTCAACTACCTT 240 ************************************************************ MzU3.8 GAATCAACACGGGCCCAGCAGTGTGATGACGACAGAAACCAAAAAAAAATGAGCCAATAG 300 ZmU3 GAATCAACACGGGCCCAACAGTGTGATGACGACAGAAAC-AAAAAAAAATGAGCCAATAG 299 ********************************************************** MzU3.8 TTCAGAAGGAGGCACTATGCAGAAACTACATTTCTGAAGGTGACTAAAAGGTGAGCGTAG 360 ZmU3 TTCAGAAGGAGGCACTATGCAGAAACTACATTTCTGAAGGTGACTAAAAGGTGAGCGTAG 359 ************************************************************ MzU3.8 AGTGTACTTACTAGTAGTTTAGCCACCATTACCCAAATGCTTTCGAGCTTGTATTAAGAC 420 ZmU3 AGTGTAATTACTAGTAGTTTAGCCACCATTACCCAAATGCTTTCGAGCTTGTATTAAGAT 419 ********************************************************* MzU3.8 TTCCTAAGCTGAGCATCATCACTGATCTGCAGG--AGGGTCGCTTCGCTGCCAAGATCAA 478 ZmU3 TTCCTAAGCTGAGCATCATCACTGATCTGCAGGCCACCCTCGCTTCGCTGCCAAGATCAA 479 ******************************************************* MzU3.8 CAGCAACCATGTGGCGGCAACATCCAGCATTGCACATGGGCTAAAGATTGAGCTCTGTGC 538 ZmU3 CAGCAACCATGTGGCGGCAACATCCAGCATTGCACATGGGCTAAAGATTGAGCTTTGTGC 539 *********************************************************** MzU3.8 CAAGTGTGAGCTGCAACCATCTAGGGATCAGCTGAGTTTATCAGTCTTTCCTTTTTTTCA 598 ZmU3 C---------------TCGTCTAGGGATCAGCTGAGGTTATCAGTCTTTCCTTTTTTTCA 584 ****************************************** MzU3.8 TTCTGGTGAGGCATCAAGCTACTACTGCCTCGATCGGTTGGACTTGGACCTGAAGCCCAC 658 ZmU3 TCCAGGTGAGGCATCAAGCTACTACTGCCTCGATTGGCTGGA------CCCGAAGCCCAC 638 ************************************************* MzU3.8 ATGTAGGATACCAGAATGGACCGACCCAGGACG-------------------------TA 693 ZmU3 ATGTAGGATACCAGAATGGGCCGACCCAGGACGCAGTATGTTGGCCAGTCCCACCGGTTA 698 ********************************** MzU3.8 GTGCCACCTCGGTTG-TCACACTGCGTAGAAGCCAGCTTAAAAATTTAGCTTTGGTGACT 752 ZmU3 GTGCCATCTCGGTTGCTCACA-TGCGTAGAAGCCAGCTTAAAAATTTAGCTTTGGTAACT 757 ******************************************************** MzU3.8 CACAGCA 759(SEQIDNO:78) ZmU3 CACAGCA 764(SEQIDNO:79) *******

[0261] Using a PCR approach with the forward primer ob2297 (SEQ ID NO: 80) and reverse primer ob2299 (SEQ ID NO: 81), the 758 bp ZmU3 promoter (ZmU3P1) (SEQ ID NO: 82) was subsequently isolated from maize genomic DNA of the maize line AxB. The forward primer ob2297 included AsiSI restriction site at its 5 end to facilitate cloning an sgRNA cassette into a pAG4500-based vector. Similarly, using a forward primer ob2343 (SEQ ID NO: 83), which contained AsiSI restriction site at its 5 end, a shorter 398 bp version of the maize U3 promoter (ZmU3P2) (SEQ ID NO: 84) was isolated for testing efficiency of a truncated maize U3 promoter. An additional variant of the ZmU3P2 was amplified with the forward primer ob2351 (SEQ ID NO: 85) that has the SwaI restriction enzyme site at its 5' end. Furthermore, a 308 bp control promoter fragment ZmU3.8P (SEQ ID NO: 86) was PCR synthesized using long primers that were designed on a MzU3.8 sequence published by Leader et al. (1994), which was shown to be expressed in maize protoplasts. The ZmU3.8P sequence also included AsiSI restriction site at the 5' end. All amplified promoter variants were cloned into pCR-Bluntll-TOPO vector (Life Technologies) and their integrity was confirmed by complete sequencing.

[0262] The sgRNA scaffold design herein is based on the published organization of an sgRNA chimera (Larson et al., 2013) and includes a 42 bp Cas9 handle hairpin (SEQ ID NO: 87) followed by a 41 bp S. pyogenes terminator (SEQ ID NO: 88). In order to improve efficiency of transcriptional termination in maize, a 37 bp putative transcription terminator sequence ZmU3T (SEQ ID NO: 89) was isolated from ZmU3 snRNA (SEQ ID NO: 77) and fused downstream of the S. pyogenes terminator (SEQ ID NO: 88). The 120 bp sgRNA scaffold (SEQ ID NO: 90) was synthesized by PCR using long primers and KOD Xtreme DNA Polymerase with the proof reading activity. The SnaBI or Ascl restriction sites were added at the 3' end of the two PCR-amplified sgRNA backbone DNA fragments to facilitate further cloning. The sgRNA scaffold DNA fragments synthesized in this way were cloned into pCR-Bluntll-TOPO vector and sequence validated.

[0263] For testing efficiency of the CRISPR/Cas system in maize, a maize gene encoding GWD was selected for the initial targeted modifications.

[0264] The maize GWD gene has been annotated earlier and was screened for the presence of AN.sub.19NGG target sequences on both sense and antisense DNA strands. The 5' end A in AN.sub.19NGG sequence represents a conserved Adenine nucleotide at the transcription start of the U3 RNA Polymerase III promoter, the 3' end positioned NGG sequence corresponds to the required for CRISPR/Cas system activity protospacer-adjacent motif (PAM) sequence. The candidate target sequences identified in exons 1, 24, and 25 as well as in their flanking introns were further screened against Maize GDB in order to eliminate sequences that have multiple identity hits within the maize genome. This work has been done to minimize chances for off-target activity of the CRISPR/Cas system. In this analysis, only the seed sequence (12 bp) of the target sequence plus two adjacent PAM nucleotides were used in BLASTN program as it was proposed by Larson et al. (2013). Exon 1 was selected for producing an almost complete GWD knockout, while exons 24 and 25 were chosen to generate GWD variants lacking an active site that is encoded by exon 24. A list of the final 19 bp GWD target sequences (SEQ ID NOS: 131-134), which were identified for sgRNA development, is compiled in Table 6.

TABLE-US-00016 TABLE6 GWDGeneTargetSequencesWithTheirCorresponding SEQIDNOS SEQID Sequence NO name Sequence GWDstrand 91 GWDe1a GGCATGAGGTGCTTACGTC antisense 92 GWDe24b CATAACCTGATACTTCAAC antisense 93 GWDe24c TCTGGCTCCTGCTATCAGT sense 94 GWDe25a TCTGCAGAAGTAGGCTTGA antisense

[0265] Each of the three variants of the maize U3 promoter, selected GWD target sequences and sgRNA backbone were assembled together by the means of fusion PCR using KOD Xtreme DNA Polymerase to construct six sgRNA expression cassettes (SEQ ID NOS: 135-140). The PCR-amplified fragments were cloned into pCR-Bluntll-TOPO vector and the integrity of the synthesized sgRNA expression cassettes was verified through sequencing. The list of the PCR-synthesized sgRNA cassettes is presented in Table 7.

TABLE-US-00017 TABLE 7 The Synthesized sgRNA Expression Cassettes with Their Corresponding SEQ ID NOS SEQ ID NO sgRNA cassette Flanking restriction sites 95 ZmU3P1:sgRNA_GWDe24b AsiSI-SnaBI 96 ZmU3P2:sgRNA_GWDe24b AsiSI-SnaBI 97 ZmU3.8P:sgRNA_GWDe24b AsiSI-SnaBI 98 ZmU3P2:sgRNA_GWDe24c AsiSI-SnaBI 99 ZmU3P2:sgRNA_GWDe25a SwaI-AscI 100 ZmU3P2:sgRNA_GWDe1a AsiSI-SnaBI

[0266] Assembled sgRNA cassettes were subsequently cloned as AsiSI-SnaBI fragments into pAG4800 to develop vectors pAG4804-4809 (Table 8).

TABLE-US-00018 TABLE 8 Vectors Developed for Maize CRISPR/Case System with SEQ ID NOS Plasmid Genetic elements pAG4800 Ubi1P:Cas9 pAG4804 U3P1:sgRNA_GWDe24b + Ubi1P:ZmCas9 pAG4805 U3P2:sgRNA_GWDe24b + Ubi1P:ZmCas9 pAG4806 U3.8P:sgRNA_GWDe24b + Ubi1P:ZmCas9 pAG4807 U3P2:sgRNA_GWDe24c + Ubi1P:ZmCas9 pAG4808 U3P2:sgRNA_GWDe1a + Ubi1P:ZmCas9 pAG4809 U3P2:sgRNA_GWDe25a + Ubi1P:ZmCas9 pAG4817 U3P2:sgRNA_GWDe25a + U3P2:sgRNA_GWDe24c + Ubi1P:ZmCas9

[0267] One additional vector pAG4817 containing two sgRNA expression cassettes was constructed by cloning ZmU3P2:sgRNA_GWDe25a cassette as SwaI-AscI fragment into pAG4807. This vector was developed for complete removal of the GWD exon 24 by targeting Cas9 endonuclease to two different sites that are located 364 bp apart within the maize GWD gene and flank exon 24.

[0268] The maps of the plant transformation vectors pAG4800 and pAG4804, which were constructed for development of CRISP/Cas system for maize are shown on FIGS. 7-8. Referring to FIG. 7, the pAG4800 vector includes the Cas9 expression cassette and the PMI expression cassette. The Cas9 expression cassette comprises a nucleotide sequence of ZmCas9 (SEQ ID NO: 75). ZmCas9 is a maize codon optimized sequence of the S. pyogenes gene encoding Cas9 fused to two At NLS at 5 and 3 ends and 3 FLAG sequence immediately after the first ATG codon. Zm Cas9 encodes the S. pyogenes Cas9 protein (SEQ ID NO: 74) containing two At nuclear localization sequences and 3FLAG sequence at N-terminal part for expression in maize. The Cas9 cassette also includes the Zm Ubil promoter, Zm Ubil intron, mUBQMono leader, and the NosT terminator. The PMI cassette includes the PMI gene, ZmUbil promoter, mUBQMono, ZmKozak leaders and the NosT terminator. Referring to FIG. 8, the pAG4804 vector includes the GWDe24b-sgRNA scaffold cassette, the Cas9 expression cassette, and the PMI expression cassette. The GWDe24b-sgRNA scaffold cassette includes ZmU3P1 promoter, GWDed24 sequence, the sgRNA scaffold and ZmU3T terminator. The Cas9 expression cassette comprises ZmCas9 fused to two At NLS at 5' and 3' ends and 3FLAG sequence immediately after the first ATG codon. The Cas9 cassette also includes the Zm Ubil promoter, Zm Ubil intron, mUBQMono leader, and the NosT terminator. The PMI cassette includes the PMI gene, ZmUbil promoter, mUBQMono, ZmKozak leaders and the NosT terminator.

Example 8

Generation of CRISPR/Cas-Induced Mutant Plants

[0269] Identification and Characterization of CRISPR/Cas and Maize NLS Meganuclease-induced Mutations in the Maize GWD Gene

[0270] Maize plant transformation was performed according to the protocol described in Example 3. Screening of CRISPR/Cas-induced mutations was similar to screening of meganuclease-induced mutations methods that has been described in Example 3 with the exception of primers for genotyping and identifying mutations.

[0271] Table 9 describes primers for genotyping CRISPR/Cas plants that include 4804-4806, 4804-6 primer set; 4809, 4817, and 4804-6 primer set substituting GWDe24a-F for GWD24b-F and primers for amplifying DNA sequences surrounding the GWD meganuclease targeting region that include 4804-4807, 4804-7mut primers; 4817, 2856/2858 primers; 4837-4839, 371/429 primers.

TABLE-US-00019 TABLE9 Primersforgenotyping4804,4805,4806,4817,4837,4838,and4839 plantsandamplifyingDNAsequencessurroundingtheGWDexon24 targetingregion Primer Forward SEQID Product PrimerSet Name orReverse Sequence NO size(bp) 4804-6 GWDe24b-F Forward CTCACAGCACATA 101 100 ACCTGATACT 4804-6 sgRNA-R Reverse CGACTCGGTGCCA 102 100 CTTT 4804-6 ZmCas9-F Forward AGAATCAGACCAC 103 186 GCAGAAG 4804-6 ZmCas9-R Reverse GCTCCTGGTCCAC 104 186 ATACATATC 4809/4817 GWDe24a-F Forward TGCAGAAGTAGGC 110 89 TTGAGTTT 4804-7mut GWDex23-F Forward TGCTCTTCTGAAC 105 560 CGATTTGA 4804-7mut ZmGWD Reverse CTATTCCTTGCTC 13 560 mega-2R GGACTGAC 4817 2856 Forward GAAGGGGATTGGA 111 613 GAGGAAG 4817 2858 Reverse CATGACGTTCAAA 112 613 TAGCCTCA 4837-4839 371 Forward GGTTATAAGCCCG 12 381 GTTGAAGTA 4837-4839 429 Reverse GCAGAAGTAGGCT 113 381 TGAAGGAA

[0272] Similar to previous analyses, DNA sequences for each mutant were compared to WT GWD using Vector NTI Advance (Version 11.5; Life Technologies). Mutant DNA sequences are described in Table 10.

[0273] Transgenic maize plants carrying gene editing constructs that target regions of the GWD gene have been produced and are being analyzed for mutations in the target regions of the GWD gene. GWD mutations and predicted proteins are listed in Tables 11-14. In these tables, events carrying two different GWD mutant alleles (heterozygotes) are labeled with 1 or 2, to indicate the individual alleles. Intronic sequences are presented in lowercase letters and exons 24 or 25 are shown in uppercase letters. Since pAG4817 is targeting two different locations within ZmGWD, two mutations are provided for 4817_2 and 4817_52. The first target sequence is located just upstream of the 5'end of the exon 24 and an extra T that is inserted into this target location is shown as a capital letter T within lowercase letters specific to intron 23 (see M37 sequence). M37 is an identical modification in 4817_2 and 4817_52.

[0274] All modifications introduced by CRISPR/Cas9 are highlighted (bold black=insertion; gray=deletion) and missing nucleotides are shown by dots. Corresponding numbers of deleted or inserted nucleotides are presented in the last columns of Tables 11 and 12.

[0275] Similarly, all changes to deduced protein sequences for M32-M39 are highlighted. In the cases of translation reading frame shifts and early termination of translation, all amino acids differing from wild type GWD are also highlighted and the end of protein is indicated by an asterisk (*).

TABLE-US-00020 TABLE 10 CRISPR/Cas9 induced mutations in individual transgenic 4804, 4806, and 4817 events Mutation Events and alleles M32 4804_2, 4804_3-2, 4804_4-1, 4804_5-2, 4806_1 M33 4804_3-1, 4804_5-1, 4804_7-1 M34 4804_4-2 M35 4804_6 M36 4804_7-2 M37, 4817_2 M38 M37, 4817_52 M39

TABLE-US-00021 TABLE11 NucleotidesequencesofCRISPR/Cas9inducedmutationsin individual4804and4806events Sequence SEQID Del/Ins Description DNAsequence NO number WT gctcctgctatcagTTGGCAGGTTATAAGCCCGGT 186 None ZmGWD TGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGT Exon24* TACTTG M32 gctcctgctatcagTTGGCAGGTTATAAGCCCGGT 114 +1 [00001] TTACTTG M33 gctcctgctatcagTTGGCAGGTTATAAGCCCGGT 115 2 [00002] TACTTG M34 gctcctgctatcagTTGGCAGGTTATAAGCCCGGT 116 3 [00003] TACTTG M35 gctcctgctatcagTTGGCAGGTTATAAGCCCGGT 117 1 [00004] TACTTG M36 [00005] 118 37 [00006] TACTTG *WT ZmGWD is a region of nt 81-160 of Exon 24 (SEQ ID NO: 3)

TABLE-US-00022 TABLE12 NucleotidesequencesofCRISPR/Cas9inducedmutationsin individual4817events SEQ Sequence ID Del/Ins Description DNAsequence NO number WtZmGWD gctcctgctatcagTTGGCAGGTTATAAGCCCGGT 187 None Exon TGAAGTATCAGGTTATGTGGTTGTGGTTGATGAGT 24* TACTTG M37 [00007] 188 +1 TTGAAGTATCAGGTTATGTGGTTGTGGTTGATGAG TTACTTG Wt CACTCTATCTGAACTTGAAGGATATGATCAGAAAC 189 None ZmGWD TGTTTTCCTTCAAGCCTACTTCTGCAGATATA Exon25 M38 [00008] 119 48 [00009] M39 CACTCTATCTGAACTTGAAGGATATGATCAGAAAC 120 +1 [00010] *WT ZmGWD is a region of nt 81-160 of Exon 24 (SEQ ID NO: 3)

TABLE-US-00023 TABLE13 Partialdeducedproteinsequencesofexon24inCRISPR/Cas9 mutants4804and4806 SEQ Sequence ID Description Proteinsequence NO WT WQVISPVEVSGYVVVVDELLAVQNKSYDKPTILVAKSVKGEEEIPDG 190 ZmGWD Exon24* M32 [00011] 121 M33 [00012] 122 M34 [00013] 123 M35 [00014] 124 M36 [00015] 125 *WT ZmGWD Exon 24 is a region of aa 1011-1057 of WT ZmGWD (SEQ ID NO: 43)

TABLE-US-00024 TABLE14 Partialdeducedproteinsequencesofexon25inCRISPR/Cas9 mutants4817 Sequence SEQID Description Proteinsequence NO WTZmGWD VLFATCFDHTTLSELEGYDQKLFSFKPTSADIT 191 Exon25* YR M38 [00016] 126 M39 [00017] 127 [00018] **WT ZmGWD Exon 25 is a region of aa 1082-1116 of WT ZmGWD (SEQ ID NO: 43)

[0276] Characterization of maize NLS meganuclease-induced mutations

[0277] To develop maize NLS meganuclease constructs pAG4837-4839, the viral SV40 NLS sequence in pAG4716 was replaced with the maize NLS sequences derived from Opaque2 (Hicks et al., PNAS,1995) (Table 15). A large variation of the induced mutations in exon 24 of the maize GWD gene was observed. These mutations included substitutions, deletions, and insertions from 1 to 114 nucleotides (Tables 16-17). Indirectly assessed efficiencies of the NLS variants were estimated as the number of events containing any modifications in the target region of the GWD gene divided by the total number of analyzed events (Table 15). Each evaluated NLS sequence supported production of the induced mutations with the NLS3 and NLS4 being the most efficient.

TABLE-US-00025 TABLE15 Meganucleaseconstructscontainingplant-derivedNLSsequences Relative Expression NLS SEQID efficiency Construct cassette number Proteinsequence NO (%) pAG4837 ZmUbi1P:NLS1: NLS1 MPTEERVRKRKES 128 59.1 GWD7-8x.226 NRESARRSRYRKA AHLKEL pAG4838 ZmUbi1P:NLS3: NLS3 MARKRKESNRESA 129 75.0 GWD7-8x.226 RRSRYRKAAHLKE L pAG4839 ZmUbi1P:NLS4: NLS4 MARKRKESNRESA 130 71.4 GWD7-8x.226 RRSRRSRYRKV

TABLE-US-00026 Table16 ListofrepresentativemutationsinducedbymaizeNLS meganucleasesinexon24oftheZmGWDgenein4837,4838,and4839events Sequence SEQID Description Mutation DNAsequence NO Del/Ins WT None GAAATACCAGATGGAGTAGTTGGTGTAATTA 192 None ZmGWD* CACCTGATATGCCAGATGTTCTGTCT 4837_12 M40 [00019] 131 3 CACCTGATATGCCAGATGTTCTGTCT 4837_12 M41 [00020] 132 2/+3 ACACCTGATATGCCAGATGTTCTGTCT 4837_16 M42 [00021] 133 1 CACCTGATATGCCAGATGTTCTGTCT 4837_19 M43 [00022] 134 3/+8 [00023] 4837_53 M44 [00024] 135 24 [00025] 4838_1 M45 [00026] 136 36 [00027] 4838_51 M46 [00028] 137 +10 [00029] TGTCT 4838_53 M47 [00030] 138 29 [00031] 4839_1 M48 [00032] 139 3 CACCTGATATGCCAGATGTTCTGTCT 4839_3 M49 [00033] 140 +1 ACACCTGATATGCCAGATGTTCTGTCT 4839_54 M50 [00034] 141 22 [00035] 4839_57 M51 [00036] 142 +19 [00037] CAGATGTTCTGTCT 4839_58 M52 [00038] 143 21 [00039] 4839_58 M53 [00040] 144 9/+2 [00041] 4839_61 M54 [00042] 145 4/+114 [00043] [00044] [00045] [00046] GATGTTCTGTCT 4839_61 M55 [00047] 146 12 CACCTGATATGCCAGATGT *WT ZmGWD is a region of nt 3157-3213 of SEQ ID NO: 1.

TABLE-US-00027 TABLE17 Partialdeducedproteinsequencesofexon24inCRISPR/Cas9 mutants4837,4838,and4839 Sequence Description Proteinsequence SEQIDNO WTZmGWD IPDGVVGVITPDMPDVLSHVSVRARNSK 193 Exon24* M40 [00048] 147 M41 [00049] 148 M42 [00050] 149 [00051] M43 [00052] 150 M44 [00053] 151 M45 [00054] 152 M46 IPDGVVGV* 153 M47 [00055] 154 M48 [00056] 155 M49 [00057] 156 M50 [00058] 157 [00059] M51 [00060] 158 M52 [00061] 159 M53 [00062] 160 M54 [00063] 161 M55 [00064] 162 *WT ZmGWD Exon 24 is a region of aa 1054-1081 of SEQ ID NO: 43.

[0278] Green Tissue Starch Assays

[0279] CRISPR/Cas and maize NLS meganuclease lines were assayed for starch in green leaf tissue. Leaf tissue harvested from 40 day old events was assayed for starch according to the protocol described in Example 3. These data confirm the efficacy of our CRISPR/Cas targeting system and maize NLS meganuclease gene editing constructs.

TABLE-US-00028 TABLE 18 Starch Content in CRISPR/Cas and Maize NLS Meganuclease Lines Starch (mg glucose/100 mg DW) Vector Event [% DW] SD WT WT 1.0 1.4 4804 58 1.1 0.1 4804 60 1.2 0.1 4804 59 1.3 0.2 4804 61 2.4 0.2 4804 53 9.3 1.9 4804 6 9.6 0.3 4804 4 11.2 1.4 4804 54 11.9 0.5 4804 51 12.4 0.9 4804 57 14.1 1.8 4804 62 16.7 0.4 4804 56 16.7 0.7 4804 7 17.0 0.6 4804 63 17.9 0.4 4804 5 18.0 0.2 4804 52 18.2 0.8 4804 3 18.5 0.9 4804 64 19.0 0.7 4804 2 19.5 1.2 4804 55 20.5 0.9 4804 1 27.8 1.7 4805 1 1.2 0.3 4805 103 11.2 0.7 4805 53 11.5 1.0 4805 56 11.7 0.7 4805 55 13.8 2.3 4805 101 14.2 0.4 4805 104 15.0 1.2 4805 51 15.0 1.2 4805 54 15.6 1.0 4805 2 16.4 0.7 4806 204 0.9 0.1 4806 203 0.9 0.1 4806 202 0.9 0.1 4806 201 1.0 0.1 4806 2 1.2 0.1 4806 52 1.2 0.6 4806 101 1.4 0.2 4806 53 1.7 0.2 4806 154 2.0 0.3 4806 57 2.2 0.7 4806 152 2.7 0.9 4806 1 3.3 0.3 4806 205 4.0 1.0 4806 207 4.6 0.6 4806 209 5.9 1.0 4806 210 7.1 0.9 4806 208 7.4 0.6 4806 155 7.5 1.0 4806 55 8.6 1.4 4806 56 9.4 1.8 4806 206 10.1 1.4 4806 54 11.0 0.9 4806 151 15.7 1.4 4807 1 0.7 0.0 4807 6 0.7 0.1 4807 5 0.7 0.1 4807 2 0.7 0.0 4807 4 1.0 0.1 4807 3 2.1 0.4 4809 1 10.1 0.8 4809 2 10.6 0.5 4809 4 13.3 0.7 4809 3 17.8 1.3 4817 54 14.2 0.7 4817 55 18.0 1.1 4817 51 19.2 0.8 4817 1 19.4 0.8 4817 53 20.7 0.5 4817 52 20.9 0.8

TABLE-US-00029 TABLE 19 Starch Content in CRISPR/Cas and Maize NLS Meganuclease 4837, 4838 and 4839 Lines Starch (mg glucose/100 mg DW Vector Event [% DW] SD WT 1 1.0 0.2 4837 8 1.3 0.2 4837 51 1.8 0.5 4837 7 1.8 0.3 4837 16 2.2 0.5 4837 4 2.3 0.2 4837 1 2.3 0.2 4837 15 2.5 0.1 4837 53 3.3 0.5 4837 9 3.6 0.5 4837 3 4.7 1.0 4837 12 6.2 1.4 4837 17 16.5 0.5 4837 11 17.0 0.7 4837 14 18.2 0.6 4837 2 18.6 1.1 4837 5 19.3 1.3 4837 19 20.0 1.1 4837 18 20.4 0.4 4837 10 22.7 2.1 4837 6 23.3 0.9 4837 52 24.7 1.4 4838 4 1.2 0.1 4838 3 1.7 0.4 4838 53 1.8 0.7 4838 2 3.3 0.4 4838 54 6.9 1.2 4838 51 19.3 1.4 4838 52 19.9 1.2 4838 1 20.0 1.4 4839 53 1.1 0.1 4839 63 1.1 0.1 4839 62 1.3 0.1 4839 52 1.4 0.2 4839 54 2.1 0.4 4839 56 2.3 0.2 4839 51 2.4 1.1 4839 57 2.7 0.3 4839 58 2.8 0.8 4839 55 22.8 1.7 4839 61 23.5 1.1 4839 60 24.5 1.1 4839 59 28.0 3.3

[0280] Referring to Tables 18 and 19, it was observed that many of the events exhibited high starch, which ranged approximately 3%-27.8%.

Example 10

Green Tissue Starch Assays

[0281] All of the CRISPR/Cas lines were assayed for starch in green leaf tissue as well as in dried stover leaves, stalks, and cobs. Leaf tissue harvested from 40 day old CRISPR/Cas events were assayed for starch according to our protocol described in Example 3. FIG. 9 illustrates starch accumulation in the pAG4804 maize events. Referring to FIG. 9, all seven T0 maize 4804 events had high starch, which ranged 9.6-27.8%, indicating that all currently unresolved GWD sequences were the result of two different GWD mutations rather than one wild type and one mutant allele (hemizygote). FIG. 10 illustrates starch accumulation in the pAG4806 maize events. Referring to FIG. 10, both TO maize 4806 events had low starch, suggesting that the one unresolved GWD sequence is a hemizygote. These data confirm the efficacy of the CRISPR/Cas targeting system herein, which includes new GWD guide RNA targeting sequences and new U3 promoters used for expression of the guide RNAs.

Example 11

Breeding Recessive Mutations for Elite Inbred Introgression and Testing

[0282] The advent of new methods for precision DNA engineering and mutagenesis provides a means of generating targeted recessive and dominant mutations for the development of new and beneficial plant traits. Some of these methods include targeting specific regions of genes with meganucleases, Talens, and the CRISPR/Cas system. Tracking and advancing targeted mutations present a new challenge for trait development, because, unlike traditional transgenic plant traits, they do not carry dominant T-DNA expression cassettes and selectable markers. Generation of targeted mutations in maize and sorghum using TALENS, ZFN, meganuclease and CRISPR/Cas methods described herein can lead to the creation of new methods for screening and breeding these unique plant traits.

Example 12

Tracking and breeding targeted mutations

[0283] Transformation (T0) Generation Genotypes: Gene-specific mutations identified using the described methods resulted in first generation transformed (T0) plants with one of three different genotypes: 1) one wild type gene allele and one mutant allele, 2) two different mutant alleles, or 3) two identical mutant alleles. These mutant allele combinations were designated as hemizygous, heterozygous, and homozygous, respectively.

[0284] Molecular Methods for Tracking Targeted Mutations: The specific sequence characteristics of a targeted DNA mutation (e.g., substitution, deletion, insertion, or combination) relative to the wild type sequence were, and may be, tracked using methods described herein when breeding the mutation into other lines, or expanding the existing lines through breeding. To differentiate wild type, hemizygous, heterozygous, and homozygous lines in a T0 and T1+ (progeny derived from T0 parental lines and beyond) segregating populations, at least five methods could be used. These methods include: 1) PCR of the mutation site with gel electrophoresis for size separation, 2) PCR with restriction enzyme digestion and gel electrophoresis to generate a mutation specific restriction pattern, 3) PCR with direct sequencing, 4) PCR with cloning and sequencing, and 5) PCR using primers that bind or do not bind to mutation sites.

[0285] Homozygous DNA sequences from either wild type or engineered, altered, or optimized endogenous nucleic acids would be easily analyzed by PCR, size determination, and, or DNA sequencing in the targeted or mutated region. In contrast, DNA sequences that possess different alleles may result in a portion of sequence that would be difficult to analyze using sequencing, PCR or size determination due to differences in the two allelic sequences (e.g., a wild type and a mutant or two different mutant sequences). PCR products from these types of targeted events would require cloning to isolate and effectively sequence each allele.

[0286] Once the sequence of the targeted mutation has been confirmed, a mutation-specific molecular strategy for tracking is established. As mentioned previously, this strategy will be dependent on the characteristics of the mutation. In tracking the gwd mutations generated herein, PCR specific reactions were developed for each of the mutations and engineered endogenous (optimized) nucleic acids described herein.

[0287] Breeding Crosses and Selfing: A main goal of developing traits with targeted mutations induced with transgenes is to isolate the mutations by separating the desired mutation from the transgene. This can be accomplished through genetic crosses and is most effective through outcrosses (higher frequency of recovered mutant plants that are transgene negative), which involves crossing T0 pollen to the female component of a non-transgenic plant. This can also be accomplished at a lower frequency using selfing, which involves self-pollinating (using T0 pollen to pollinate the same T0 plant). Sibbing is another option and involves crosses between two genetically identical plants, which would be expected to have the same outcome as a self-cross.

[0288] T0 plants carrying targeted mutations can be selfed to generate homozygous plants and would result in different numbers and types of progeny depending on the T0 zygosity. Homozygous T0 plants would generate 100% homozygous progeny, hemizygous T0 plants would segregate 1:2:1 (homozygous: hemizygous: wild type) for the mutant allele, and heterozygous TO plants would segregate 1:2:1 (homozygous targeted allele 1: heterozygous: homozygous targeted allele 2).

[0289] T0 plants carrying targeted mutations can also be outcrossed into other lines and would result in different numbers and types of progeny depending on the T0 zygosity. Homozygous T0 plants would generate 100% hemizygous progeny, hemizygous T0 plants would generate 50% hemizygous progeny and 50% wild type progeny, and heterozygous T0 plants would generate hemizygous progeny, 50% with targeted allele 1 and 50% with targeted allele 2.

[0290] Because all T0 plants would be carrying transgenes, the transgene insertion location is most commonly different, and the number of transgene insertions could differ, the segregation patterns for the transgenes have the potential to vary considerably between each T0 transformation event/plant. To identify transgene-negative plants, PCR would be applied to the progeny from any cross (self, sib, or outcross) with T0 plants. Transgene-negative plants would be identified by the absence of a transgene-specific PCR product. The transgene-negative plants would then be screened for the targeted mutation using the molecular diagnostics approach defined during the initial characterization of the T0 plants.

[0291] Targeted mutations isolated from the transgene can then be maintained and bred for testing and introgressions with the continued use of the trait-specific molecular diagnostics protocol.

[0292] An Example Tracking and Breeding Procedure for a Targeted Mutation: The molecular tracking and breeding procedure for a targeted mutation is described herein. Tracking of the GWD gene from maize (M20, ZmGWD_M20 from event 4716_164) is described herein. Generation and initial sequence characterization of this and other meganuclease-induced targeted mutations in maize and sorghum has been described in Examples herein. T0 4716_164 plants were hemizygous for the M20 mutation initially and carried an unknown number of T-DNA insertions. The M20 mutation is a recessive single base pair (bp) deletion in exon 24 of ZmGWD, which results in a mutation at an MluCI restriction enzyme site in the wild type sequence. The small size of this deletion required use of the MluCI RFLP with gel electrophoresis because it could not be differentiated from wild type with gel electrophoresis alone.

[0293] FIG. 11 illustrates a schematic drawing of selfing and outcrossing of a targeted mutation M20 derived from the maize event 4716_164. Referring to FIGS. 11, T0 4716_164 plants were selfed and outcrossed to generate progeny for efficacy testing and introgressions, respectively. To identify homozygous M20 progeny from the T0 selfed parent, PCR with the meganuclease targeting gene and the target region of the GWD gene was performed. FIG. 12 illustrates genotyping of T1 progeny from the selfed T0 4716_164 M20 plant. Referring to FIG. 12, PCR products from meganuclease GOI and ZmGWD target region were digested with MluCI, separated on 5% polyacrylamide and stained with ethidium bromide. This revealed plants that did not carry the T-DNA (Meganuclease) but were homozygous for M20. These plants were maintained for testing.

[0294] To identify hemizygous M20 progeny from the T0 outcrossed parent, PCR of the selectable marker gene, PMI, the meganuclease gene, and the target region was performed, followed by 3% agarose gel electrophoresis and ethidium bromide staining. This also allowed identification of T-DNA negative plants. FIG. 13 illustrates genotyping of T1 progeny from the outcrossed T0 4716_164 M20 plant. MluCI restriction digests were then performed on the same PCR products from T-DNA negative plants and separated them on a 5% polyacrylamide gel stained with ethidium bromide. FIG. 14 illustrates genotyping of T1 progeny from the outcrossed 4716_164 M20 plant. These plants were maintained for further introgressions and future testing.

REFERENCES

[0295] An, G et al., 2005. Reverse genetic approaches for functional genomics of rice. Plant molecular biology, 59(1), pp. 111-23. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16217606 [Accessed Jul. 25, 2012]. [0296] Arnould S, Perez C, Cabaniols J P, Smith J, Gouble A, Grizot S, Epinat J C, Duclert A, Duchateau P, Paques F. (2007) Engineered I-CreI derivatives cleaving sequences from the human XPC gene can induce highly efficient gene correction in mammalian cells. J. Mol. Biol. 371: 49-65. [0297] Arnould S, Delenda C, Grizot S, Desseaux C, Paques F, Silva G H, Smith J. (2011) The I-CreI meganuclease and its engineered derivatives: Applications from cell modifi cation to gene therapy. Protein Eng. Des. Sel. 24: 27-31. [0298] Belhaj K, Chaparro-Garcia A, Kamoun S, Nekrasov V. (2013) Plant genome editing made easy: targeted mutagenesis in model and crop plants using the CRISPR/Cas system. Plant Methods 9: 39-48. [0299] Boch J. & Bonas U. (2010) Xanthomonas AvrBs3 family-type III effectors: discovery and function. Annu. Rev. Phytopathol. 48: 419-436. [0300] Cermak T, Doyle E L, Christian M, Wang L, Zhang Y, Schmidt C, Baller J A, Somia N V, Bogdanove A J, Voytas D F. (2011) Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res. 39: e82 [0301] Chi-Ham CL et al., 2010. The intellectual property landscape for gene suppression technologies in plants. Nature Biotechnology, 28 (1):32-36. [0302] Christian, M et al., 2010. Targeting DNA double-strand breaks with TAL effector nucleases. Genetics, 186(2), pp. 757-61. Available at: http://www.pubmedcentral.nih. gov/articlerender.fcgi?artid=2942870 &to ol=pmcentrez&rendertype=abstract [Accessed Jul. 14, 2012]. [0303] Cong L, Ran F A, Cox D, Lin S, Barretto R, Habib N, Hsu P D, Wu X, Jiang W, Marraffini L A, Zhang F. (2013) Multiplex genome engineering using CRISPR/Cas systems. Science 339: 819-823. [0304] Djukanovic V, Smith J, Lowe K, Yang M, Gao H, Jones S, Nicholson M G, West A, Lape J, Bidney D, Falco S C, Jantz D, Lyznik L A. (2013) Male-sterile maize plants produced by targeted mutagenesis of the cytochrome P450-like gene (MS26) using a re-designed I-CreI homing endonuclease. The Plant Journal 76: 888-899. [0305] Elkonin L A, Pakhaomova N V. (2000) Influence of nitrogen and phosphorus on induction embryogenic callus of sorghum. Plant Cell Tissue and Organ Culture 61: 115-123. [0306] Frizzi A & Huang S, 2010. Tapping RNA silencing pathways for plant biotechnology. Plant biotechnology journal, 8(6), pp. 655-77. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20331529 [Accessed Jul. 24, 2012]. [0307] Gao Z, Xie X, Ling Y, Muthukrishnan S, Liang G H. (2005) Agrobacterium tumefaciens-mediated sorghum transformation using a mannose selection. Plant biotechnology journal, 3, pp. 591-599. [0308] Garcia-Bustos J, Heitman J, Hall M N (1991) Nuclear protein localization. Biochim Biophys Acta 1071: 83-101. [0309] Gasiunas G, Barrangou R, Horvath P, Siksnys V. (2012) Cas9crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci USA. 109 (39): 2579-2586. [0310] Goujon M et al., 2010 A new bioinformatics analysis tools framework at EMBL-EBI (2010) Nucleic acids research Jul, 38 Suppl: W695-9 doi:10.1093/nar/gkq313 [0311] Heath P J, Stephens K M, Monnat R J Jr., Stoddard B L. (1997) The structure of I-Crel, a group I intron-encoded homing endonuclease. Nat. Struct. Biol. 4: 468-76. [0312] Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna J A, Charpentier E. (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337: 816-821. [0313] Joung J K & Sander J D. (2013) TALENs: a widely applicable technology for targeted genome editing. Nature Reviews (Mol Cell Biol) 14: 49-55. [0314] Kalderon D, Richardson W D, Markham A F, Smith A E (1984) Sequence requirements for nuclear location of simian virus 40 large T antigen. Nature 311: 33-38. [0315] Larkin M A et al., 2007 ClustalW and ClustalX version 2 Bioinformatics, 23(21): 2947-2948. doi:10.1093/bioinformatics/btm404 [0316] Larson M H, Gilbert L A, Wang X, Lim W A, Weissman J S, Qi L S. (2013) CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nat. Protoc. 8(11): 2180-2196. [0317] Leader D J, Connelly S, Filipowicz W, Brown J W S. (1994) Characterisation and expression of a maize U3 snRNA gene. Biochimica et Biophysica Acta 1219: 145-147. [0318] Liang Z, Zhang K, Chen K, Gao C. (2014) Targeted mutagenesis in Zea mays using TALENs and the CRISPR/Cas System. Journal of Genetics and Genomics 41: 63-68. [0319] Li T, Huang S, Jiang W Z, Wright D, Spalding M H, Weeks D P, Yang B. (2011) TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domain. Nucleic Acids Res. 39: 359-372. [0320] Maniatis T, Fritsch E F and J. Sambrook J, 1982. Molecular Cloning Cold Spring Harbor Laboratory. [0321] Puchta H, Dujon B and Hohn B, 1993. Homologous recombination in plant cells is enhanced by in vivo induction of double strand breaks into DNA by a site-specific endonuclease. Nucleic acids research, 21(22), pp.5034-40. Available at: http ://www.pubmedcentral.nih.gov/articlerender fcgi?artid=310614&too1=pmcentrez&rendertype=abstract. [0322] Raikhel N V (1992) Nuclear targeting in plants. Plant Physiol 100: 1627-1632. [0323] Rosen L E et al., (2006) Homing endonuclease I-CreI derivatives with novel DNA target specificities. Nucleic Acids Res. 34: 4791-4800. [0324] Shieh M W et al., (1993) Nuclear targeting of the maize R protein requires two nuclear localization sequences. Plant Physiology 101: 353-361. [0325] Shukla V K et al. (2009) Precise genome modification in the crop species Zea mays using zinc-finger nucleases. Nature 459: 437-441. [0326] Sikora P et al., 2011. Mutagenesis as a tool in plant genetics, functional genomics, and breeding. International journal of plant genomics, 2011, p.314829. Available at: http ://www.pubmedcentral.nih.gov/articlerender fcgi?artid=3270407&tool=pmcentrez&rendertype=abstract [Accessed Jul. 25, 2012]. [0327] Smith A M and Zeeman S C, 2006. Quantification of starch in plant tissues. Nat. Protocols 1:1342-1345. [0328] Smith T F, Waterman M S, 1981. Identification of Common Molecular Subsequences. J Mol Biol 147: 195 -197. [0329] Symington L S, Gautier J. (2011) Double-Strand Break End Resection and Repair Pathway Choice. Annual Review of Genetics. 45: 247-271. [0330] Till B J et al., 2007 Discovery of chemically induced mutations in rice by TILLING. BMC Plant Biol. 7:19. [0331] Upadhyay S K et al., (2014) RNA-guided genome editing for target gene mutations in wheat. Genes, Genomes, Genetics 3: 2233-2238. [0332] Vainstein A et al., 2011. Permanent genome modifications in plant cells by transient viral vectors. Trends in biotechnology, 29(8), pp. 363-9. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21536337[Accessed Jul. 30, 2012]. [0333] Varagona M J et al., (1992) Nuclear localization signal(s) required for nuclear targeting of the maize regulatory protein Opaque-2. The Plant Cell 4: 1213-1227. [0334] Wagner P et al.,1990) Active transport of proteins into the nucleus. FEBS 275: 1-5. [0335] Wehrkamp-Richter S et al., 2009. Characterisation of a new reporter system allowing high throughput in planta screening for recombination events before and after controlled DNA double strand break induction. Plant physiology and biochemistry: PPB/Socitfranaise de physiologie vgtale, 47(4), pp. 248-55. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19136269 [Accessed Jul. 17, 2012] [0336] Weise, S. E. et al., (2012) Engineering starch accumulation by manipulation of phosphate metabolism of starch. P. Biotech. J. 10, 545-554. [0337] Wright D et al., 2005. High-frequency homologous recombination in plants mediated by zinc-finger nucleases. The Plant journal: for cell and molecular biology, 44(4), pp. 693-705. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16262717 [Accessed Jul. 19, 2012]. Yon J, Fried M. (1989) Precise gene fusion by PCR. Nucleic Acids Res. 17 (12): 4895. [0338] Larkin M A et al., 2007 ClustalW and ClustalX version 2 Bioinformatics, 23(21): 2947-2948. doi:10.1093/bioinformatics/btm404 [0339] Goujon M et al., 2010 A new bioinformatics analysis tools framework at EMBL-EBI (2010) Nucleic acids research Jul., 38 Suppl: W695-9 doi:10.1093/nar/gkq313

[0340] The references cited throughout this application, are incorporated for all purposes apparent herein and in the references themselves as if each reference was fully set forth. For the sake of presentation, specific ones of these references are cited at particular locations herein. A citation of a reference at a particular location indicates a manner(s) in which the teachings of the reference are incorporated. However, a citation of a reference at a particular location does not limit the manner in which all of the teachings of the cited reference are incorporated for all purposes.

[0341] It is understood, therefore, that the invention is not limited to the particular embodiments disclosed, but is intended to cover all modifications which are within the spirit and scope of the invention as defined by the appended claims; the above description; and/or shown in the attached drawings.